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 Executive summary  
 
Around half of us will be diagnosed with 
cancer in our lifetimesi. There are around 
280,000 new cancer diagnoses in England 
every yearii and this is set to increase 
considerably as we live longer. Cancer 
survival is at its highest ever level, but the 
NHS in England is under considerable 
pressure. The ’62-day wait’ target - which 
states that 85% of cancer patients should 
receive treatment within 62 days of being 
urgently referred for suspected cancer by 
their GP – has now been breached for six 
consecutive quarters. This is indicative of 
pressures across the pathway – from 
seeing a specialist, to receiving a test, to 
getting results, and ultimately 
commencing treatment. New NICE 
guidelines on referral for suspected cancer 
are likely to exacerbate demand, as are 
changes to the bowel cancer screening 
programme. Action is now needed to 
ensure services are equipped to cope with 
rising demand.  
 
Cancer Research UK commissioned this 
research to understand the pressures 
facing endoscopy services in England as a 
result of rising demand and to identify 
solutions for addressing these issues. 
Managing future demand and ensuring 
diagnostics can cope will be essential to 
improve cancer outcomes through early 
diagnosis. When cancer is diagnosed at an 
early stage, treatment options and chances 
of a full recovery are greater.   
A number of challenges facing endoscopy 
services were identified through this 
research. These included: 
• Rising demand for endoscopy services 
and a lack of capacity to respond to 
this increasing demand;  
• More than 750,000 additional 
endoscopy procedures a year will be 
undertaken by 2020 – this is more than 
the population of Leeds and represents 
a 44 per cent increase on current 
activity; 
• Workforce issues, including 
recruitment, retention, evening and 
weekend working and training and 
development; 
• A need to improve productivity and 
efficiency, but a lack of ‘headspace’ to 
do so; 
• Issues with data availability, quality and 
use. 
 
Background 
 
Endoscopy plays a vital role in the 
diagnosis of, and ongoing surveillance for 
gastrointestinal cancers, including bowel 
and oesophageal cancer. Endoscopy is 
also performed for the diagnosis, 
surveillance and treatment of a wide range 
of conditions and diseases that are not 
cancer-related. This study therefore 
considers the entire endoscopic service, 
and not just the ability of units to respond 
to increased demand for endoscopies 
related to cancer diagnoses or surveillance.  
 
Demand for lower gastrointestinal 
endoscopies i.e. colonoscopy and flexible 
sigmoidoscopy has been reported as 
doubling between 2012 and 2017iii. In a 
financially constrained environment (the 
NHS is required to find £22bn in efficiency 
savings) increased demand will inevitably 
place pressure on endoscopy units. 
 
A significant amount of work has been 
undertaken in the last 20 years to develop 
endoscopy services in order to improve 
quality, productivity and patient 
experience. However, in spite of these 
improvements, a more recent rapid review 
by the NHS Improvement Agency (2012) 
concluded that services were still 
encountering some key challenges in 
planning for increased demand and 
increasing capacity.  
 
 
Research aims 
 
Given the importance of endoscopy 
services within the cancer pathway it is 
critical that the organisation of this aspect 
of diagnosis, surveillance and treatment 
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delivers the capacity required. In light of 
this context and evidence, Cancer 
Research UK commissioned a research 
team from the Health Services 
Management Centre, University of 
Birmingham and the Strategy Unit at NHS 
Midlands and Lancashire Commissioning 
Support Unit to undertake an evaluation of 
endoscopy capacity across the NHS in 
England to address the following key aims:  
• Improve knowledge of current upper 
and lower gastrointestinal (G.I) 
endoscopy capacity in England; 
• Ascertain by how much demand is 
likely to grow; 
• Identify levels of resource (including 
staffing, equipment and facilities) 
necessary to meet growing demand; 
• Estimate shortfalls in these resources, 
and; 
• Understand what is causing this and 
how it can be addressed.  
 
The findings of this report were shared 
with the Independent Cancer Taskforce, to 
inform the recently published cancer 
strategy, Achieving World-Class Cancer 
Outcomes: a Strategy for England 2015-
2020. While this report shows a 
considerable gap between current 
capacity and demand for endoscopy 
services, if the Government and NHS 
bodies act to implement the 
recommendations of Achieving World-
Class Cancer Outcomes, significant 
progress will be made towards delivering 
world class diagnostic services. 
 
Recommendations 
 
Meeting rising demand 
Though many units described the steps 
they had already taken to respond to rising 
demand, the overriding impression from 
interviewees and survey respondents is of 
a service under increasing pressure. While 
units appear to have been managing 
waiting times to cope with increases in 
demand this has often meant putting on 
regular waiting list initiative sessions at 
weekends and in the evenings, or bringing 
in external staff through private companies 
to use their facilities during these times. 
These arrangements come with attendant 
additional costs which are ultimately 
unsustainable. 
 
1. The Government should increase 
investment in diagnostic services, as 
set out in Achieving World-Class 
Cancer Outcomes, to ensure the 
NHS can meet rising demand and 
that our cancer outcomes become 
the best in the world. This should 
include a dedicated £125 million 
diagnostics fund over five years. For 
endoscopy specifically, investment 
will be needed to recruit and train 
new members of the workforce and 
replace ageing equipment. 
 
2. NHS England and Public Health 
England should ensure learnings 
from the bowel screening 
programme are applied across the 
symptomatic pathway so there is not 
a two-tier system and patients 
receive a consistently high level of 
care regardless of their route into the 
health system. 
 
Workforce 
Staff shortages were commonly cited as 
the biggest barrier for units in managing 
demand. Though there were some issues 
mentioned in specific areas about a lack of 
physical space, many units have addressed 
this in recent years. However, using this 
additional capacity requires the appropriate 
workforce, including Consultant 
Gastroenterologists, Consultant GI 
Surgeons, Non-medical Endoscopists 
(including Nurse Endoscopists) and Senior 
Endoscopy Nurses.  
 
There is some degree of variation between 
units as to where on the pay-scale Nurse 
Endoscopists sit which appears to be 
unwarranted in some cases. There were 
also concerns about staff experiencing 
stress and ‘burn out’ along with the 
potential for physical problems to develop, 
such as repetitive strain injury, as a result of 
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increasing the extent to which staff scope 
patients. 
 
3. Strategic planning around workforce 
should happen at the national level, 
as stated in Achieving World-Class 
Cancer Outcomes. Health Education 
England is working with NHS 
England to deliver a training and 
development programme for Non-
medical Endoscopists; this work 
should also include a robust 
assessment to determine the 
required number of trainees based 
on rising demand. Similar steps 
should be taken to ascertain the 
required level of new Consultant 
Gastroenterologists, Consultant GI 
Surgeons and Senior Endoscopy 
Nurses.  
 
4. Commissioners should work with 
local services to ensure the 
protection of training lists so that 
staff are adequately trained.  
 
5. Leadership teams should ensure the 
unwarranted variation between units 
in Nurse Endoscopists’ pay is 
eliminated.  
 
6. NHS England and the Department of 
Health should work to ensure all staff 
involved in the delivery of 
endoscopy services are prepared for 
the transition to 7-day working. This 
should involve the management of 
expectations from the recruitment 
stage, and the provision of 
appropriate compensation. In 
addition, local services should 
ensure job plans are appropriately 
balanced to encourage retention 
and avoid burn out. 
 
Service Development and Improvement 
The work of the Joint Advisory Group on 
Gastrointestinal Endoscopy (JAG) and its 
accreditation process are internationally 
recognised as improving quality and 
productivity within endoscopy services as a 
whole, while strong clinical leadership was 
also highlighted as an important factor in 
ensuring the endoscopy service has a 
strong profile within its own organisation.  
 
NHS IQ has recently produced the 
‘Productive Endoscopy’ toolkit to support 
productivity and efficiency. This is now 
available to all units though its use is not 
yet widespread. However, many units felt 
that the ‘low-hanging fruit’ had already 
been addressed in their units and that any 
other improvement activities would require 
further resource. For example, a number of 
survey respondents commented that their 
Trusts were delaying replacing ageing 
equipment because of financial restraints. 
 
The toolkit recommends the introduction 
of GP direct access to endoscopy where 
this does not already exist. The ACE 
(Accelerate, Co-ordinate, Evaluate) 
Programme is expected to produce 
evidence on best practice for innovative 
pathways, including GP direct access, 
which is mandated by both Improving 
Outcomes: a Strategy for Cancer and 
Achieving World-Class Cancer Outcomes. 
Respondents highlighted that the quality of 
GP referrals was variable and in places 
could be improved. Similarly, consultant-
to-consultant referrals were also 
highlighted as a potential area for 
improvement. 
 
7. NHS England should support 
services to achieve and maintain JAG 
accreditation. Services should also 
be encouraged and enabled through 
the commissioning process to make 
use of appropriate productivity tools. 
 
8. Commissioners should consider 
innovative ways to meet rising 
demand, including alternative 
pathways and processes, such as 
supporting Straight to Test access to 
endoscopy through telephone 
triage/pre-assessment which would 
help to speed up diagnosis. In 
addition, increased collaboration 
between endoscopy units and 
strengthening links at the interface 
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between primary and secondary care 
could help to improve the quality 
and appropriateness of referrals.  
 
Data Quality and Access 
The datasets relating to endoscopy need 
improving so that it is possible to ascertain 
the reason why a patient has been referred 
for endoscopy (i.e. for surveillance, 
screening or symptomatic reasons). A 
National Endoscopy Database is in 
development, overseen by the JAG.  
 
The data published on the activity and 
outcomes of the National Bowel Cancer 
Screening Programme is not as 
comprehensive as the data routinely 
published for other Cancer Screening 
Programmes (Breast and Cervical). Public 
Health England is working to produce data 
returns for publication, with the first return 
available in December 2015 (KC73) and a 
further return (KC72) by 2016. Data returns 
in their final form, will be developed by 
2020.  The process of assessing and 
processing information requests for 
researchers, which would not disclose 
patient identifiable information, could be 
streamlined.  
 
9. The Health and Social Care 
Information Centre (HSCIC) should 
work with endoscopy providers to 
ensure that Hospital Episode 
Statistics (HES) contains a complete 
and accurate record of all NHS 
commissioned endoscopies, making 
changes to data specifications to 
identify whether a procedure is for 
surveillance, screening or 
symptomatic purposes. 
 
10. Public Health England should work 
to ensure data on the activity and 
outcomes of the Bowel Cancer 
Screening Programme is routinely 
published in a format consistent with 
the breast and cervical screening 
programmes. Public Health England 
should also work to ensure there is 
timely access for researchers to 
appropriate data about the Bowel 
Cancer Screening Programme. 
 
New Technologies 
Given the scale of the anticipated increase 
in demand for endoscopy services (see 
Figure 1. below), it is essential that any new 
technologies that are likely to increase 
demand in the future are properly planned 
for. One such example which is likely to 
increase demand on services is the 
introduction of the Faecal 
Immunochemical Test (FIT) to replace the 
Faecal Occult Blood Test (FOBT) as the 
primary test in the Bowel Cancer 
Screening Programme. 
 
11. Public Health England (PHE), NHS 
England and the National Screening 
Committee (NSC) should undertake 
a strategic planning process to 
ascertain how best to manage the 
pressures which will inevitably be 
created in endoscopy services by the 
introduction of the Faecal 
Immunochemical Test (FIT) into the 
Bowel Cancer Screening 
Programme. Similarly, the ongoing 
rollout of Bowel Scope into the 
Screening Programme should take 
into account the pressures services 
are currently facing. Services should 
be supported to roll out these tests 
as swiftly as possible. 
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Figure 1: Modelled changes in endoscopy activity 2013/14 to 2019/20 (figures 
shown in thousands) 
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1. Introduction  
 
Around half of us will be diagnosed with 
cancer in our lifetimesiv. There are around 
280,000 new cancer diagnoses in England 
every yearv and this is set to increase 
considerably as we live longer. Cancer 
survival is at its highest ever level, but the 
NHS in England is under considerable 
pressure. The ’62-day wait’ target - which 
states that 85% of cancer patients should 
receive treatment within 62 days of being 
urgently referred for suspected cancer by 
their GP – has now been breached for six 
consecutive quarters. This is indicative of 
pressures across the pathway – from 
seeing a specialist, to receiving a test, to 
getting results, and ultimately 
commencing treatment. Action is now 
needed to ensure services are equipped to 
cope with rising demand.  
 
Endoscopy plays a vital role in the 
diagnosis of, and ongoing surveillance for 
gastrointestinal cancers, including bowel 
and oesophageal cancer. An endoscope is 
a long, thin, flexible tube with a light 
source and video camera at one end to 
relay images from the inside of the body. 
An endoscope can be used to remove a 
small sample of tissue for biopsy and can 
also be used therapeutically to carry out 
certain surgical procedures such as the 
removal of polyps from the bowel. 
Endoscopic tests are therefore used: 
• To assess symptomatic patients 
referred by their GP on the urgent 
‘two-week wait’ pathway,  
• To assess symptomatic patients 
presenting through other routes;  
• To assess non-symptomatic 
patients as part of the National 
Bowel Cancer Screening 
Programme in England; 
• For surveillance of people who 
exhibit risk factors for lower and 
upper GI cancers such as Crohn’s 
disease, ulcerative colitis and 
Barrett’s Oesophagus;  
• In emergency situations when in-
patients develop a gastrointestinal 
(GI) bleed that requires immediate 
investigation.  
 
The exact nature of the service provided by 
endoscopy units and their configuration 
varies across the country. Some acute-
based units are stand-alone units while 
others operate as part of a Day Surgery 
unit. There are a number of NHS 
endoscopy units based outside of hospitals 
within the community and a number of 
independent units that deliver NHS 
endoscopic services. Many acute-based 
units also deliver a wider range of 
procedures than Upper GI and Lower GI 
endoscopic tests alone, such as 
cystoscopies1 and bronchoscopies2, 
though the primary focus of this study is GI 
endoscopy. Endoscopic tests, and other 
activity undertaken within endoscopy units, 
are not just provided for patients with, or 
suspected of having, cancer. Endoscopic 
tests are performed for the diagnosis, 
surveillance and treatment of a wide range 
of conditions and diseases that are not 
cancer-related. This study therefore 
considers the entire endoscopic service, 
and not just the ability of units to respond 
to increased demand for endoscopies for 
cancer pathways.  
 
Historically, endoscopy services were 
perceived to be performing below 
expected standards with reports of low 
caecal intubation rates, insufficient training 
and long waiting times.  The establishment 
of the Joint Accreditation Group for GI 
Endoscopy (JAG)3 in 1994 saw the start of 
a significant amount of work to develop 
endoscopy services in order to improve 
quality, productivity and patient 
experience. This included the rigorous 
                                                        
1
 A cystoscopy is a procedure that examines 
the inside of the bladder 
2
 A bronchoscopy is a procedure that examines 
the lungs 
3
 The Joint Advisory Group on GI Endoscopy 
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process of accreditation4 that units now 
aspire to achieve and maintain, as well as 
initiatives to support training and quality 
improvement such as programmes led 
initially by the Modernisation Agency and 
later, NHS Improvement and NHS 
Improving Quality.   
 
However, in spite of the improvements 
witnessed in endoscopy services as a result 
of these efforts, a more recent rapid review 
of endoscopy services by the NHS 
Improvement Agencyvi concluded that 
endoscopy services were still 
encountering some key challenges in 
planning for increased demand and 
increasing capacity.  
It is expected that the number of 
endoscopic procedures required in the UK 
will increase significantly over the next few 
years. For example, demand for lower 
gastrointestinal endoscopies i.e. 
colonoscopy and flexible sigmoidoscopy 
has been reported as doubling between 
2012 and 2017vii while it is estimated the 
increase would be in the region of an extra 
400,000 flexible sigmoidoscopy 
procedures and 20,000 colonoscopies 
each yearviii.  There are a number of factors 
which will contribute towards this increase. 
These include: 
• The prevalence and incidence of 
diseases:  The prevalence of bowel 
cancer is increasing and is anticipated 
to reach 188,000 cases in men and 
152,000 cases in women by 2020ix; 
• Demographic factors: The UK 
population is projected to increase to 
68 million by mid-2022, equivalent to 
an annual growth rate of 0.6%x; the 
proportion aged 65 or over is projected 
to be around one fifth to one quarter of 
                                                        
4
 JAG accreditation is the formal recognition 
that an endoscopy service has demonstrated 
that it has the competence to deliver against 
the measures in the endoscopy GRS (Global 
Rating Scale) Standards. The GRS also includes 
a knowledge management system which 
allows good practice to be shared.  
the population across all regions of the 
UK; 
• National screening programmes:  The 
National Bowel Cancer Screening 
Programme (BCSP) has expanded in 
reach since its introduction in 2006 
when it offered biennial Faecal Occult 
Blood testing (FOBT)5 screening to 60-
69 year olds. In 2009 roll out began to 
include 70-74 year olds. The 
introduction of the bowel scope 
screening programme in 2013 offers a 
one-off flexible sigmoidoscopy 
screening test for people over 55.  The 
national rollout of the Bowel Scope 
Screening Programme is expected to 
increase the number of flexible 
sigmoidoscopy procedures by 325,000 
procedures a year by 2016/17xi  
• National campaigns, such as Be Clear 
on Cancer, have sought to increase 
public awareness of the signs and 
symptoms of various forms of cancer; 
• Current national policy and guidance: 
(National Institute for Health and Care 
Excellence) NICE guidance includes 
recommendations for types of test and 
referral guidelines, including indicators 
for urgent and 2-week pathway 
referrals; new guidance on suspected 
cancer is in progress, which may 
impact primary care referrals, and   
• Surveillance protocols for people at 
enhanced riskxii. 
In a financially constrained environment, 
(the NHS is required to find £22bn in 
efficiency savings by 2020 to contribute 
towards the £30bn identified funding 
gapxiii) this will inevitably place pressure on 
endoscopy units to manage the increased 
demand. The median waiting time in 
England substantially decreased between 
2006 and 2009 for the four endoscopy 
diagnostic tests, especially colonoscopy. 
However, since 2009, the median waiting 
time for all tests has increasedxiv. There is 
also evidence to suggest that patients on 
surveillance programmes are experiencing 
                                                        
5
 The guaiac FOBT or faecal occult blood test 
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delays in their diagnostic tests, due to the 
requirement to see new patients within 
monitored target timesxvxvi. 
 
This report aims to ascertain the barriers to 
meeting rising demand for endoscopy 
services and offers solutions for how best 
these can be overcome. It complements 
the 2020 Delivery report for Cancer 
Research UK, ‘Horizon scanning: an 
evaluation of imaging capacity across the 
NHS in England’ which undertook a similar 
assessment of diagnostic imaging services. 
Taken together, these reports describe a 
picture of England’s diagnostic services 
facing considerable strain and requiring 
significant action if patient outcomes are 
to improve and not deteriorate. 
  
 1.1 National policy and guidance 
 
National policy and guidance on endoscopy is important to ensure there is a clear vision for 
the service and so that services know what best practice entails. This is especially important in 
the light of new technologies being introduced into the bowel cancer screening programme 
and to eradicate unacceptable variation where this exists. 
 
Table 1 lists current NICE guidance and quality standards which include recommendations on 
gastrointestinal endoscopy.  The guidance outlines the indicators for immediate and urgent 
referrals (e.g. upper gastrointestinal bleeding) and 2-week pathway referrals for suspected 
cancer.  For diagnostic endoscopy, colonoscopy and flexible sigmoidoscopy are 
recommended, with CT colonography as an alternative for patients not suitable for 
colonoscopy.  Barium enema is not recommended in the diagnosis and management of 
cancer.   
Table 1 – current NICE guidance 
 Guidance document 
Cancer Referral guidelines for suspected cancer CG27
xvii
 
Colorectal cancer CG131
xviii
  
Colorectal cancer QS20
xix
 
Coeliac Disease Coeliac disease CG86
xx
 (To be updated Sep 2015) 
Dyspepsia and GORD Dyspepsia and GORD CG184
xxi
  
GORD in children and young people NG1
xxii
  
Gallstones Gallstones CG188
xxiii
  
Barretts Oesophagus  Barretts Oesophagus CG106
xxiv
  
Inflammatory bowel disease Inflammatory bowel disease QS81
xxv
  
Colonoscopic surveillance CG118
xxvi
  
Irritable bowel syndrome Irritable bowel syndrome CG61
xxvii
  
Acute upper GI bleeding Acute upper gastrointestinal bleeding CG141
xxviii
  
Acute upper gastrointestinal bleeding QS38
xxix
  
An update of the referral guidance for suspected cancer was published in June 2015.  The 
new guidance includes a number of changes, which may impact the number of referrals 
from primary care, including:  
• The duration of symptoms has been removed for both lower and upper 
gastrointestinal suspected cancers (previously 6 weeks); 
• GPs should be offered urgent direct access to upper gastrointestinal endoscopies; 
• The surveillance of Barrett’s Oesophagus is no longer recommended in cases where 
the risks of the procedure may outweigh the benefits. 
In addition to NICE, guidance is also issued by professional bodies, for example, the British 
Society of Gastroenterology’s guidelines on the diagnosis and management of Barrett’s 
Oesophagusxxx; the Association of Upper Gastrointestinal Surgeons of Great Britain and 
Ireland’s guidelines for the management of oesophageal and gastric cancerxxxi.  There are also 
international guidelines, including position statements from European Society of 
Gastrointestinal Endoscopy (ESGE) on quality in screening colonoscopyxxxii. 
There is some concern in the literature regarding adherence to such guidance.  The Atlas of 
Variation for Diagnostic Servicesxxxiii shows a 172-fold variation in the use of barium enema, 
which is no longer considered an effective test for detecting cancer. Bowel Cancer UKxxxiv 
found that one third of patients who had a barium enema test had to return later for another 
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test (in a survey of 708 people). It is suggested that this variation may be due to insufficient 
access to CT and optical colonoscopies. CT colonography is accepted as an alternative 
where colonoscopy is not appropriatexxxv but it is noted that further investigations may be 
required to confirm diagnosis, which could lead to variation.  Nationally, steps are being taken 
to address the continued use of barium enema.  
A clinical audit conducted across the Kent and Medway Cancer Networkxxxvi assessed 
compliance with guidance from the Association of Coloproctology of Great Britain and 
Ireland (ACPGBI) and the British Society of Gastroenterology (BSG) on colorectal cancer 
screening and surveillance. The review of 3,020 case notes identified that whereas 22% of 
planned surveillance colonoscopies were in line with guidance, 51% could be cancelled from 
the list and 27% could be given a revised date.  Each of the endoscopy services who 
participated was given their results with the recommendation that they update their waiting 
lists accordingly and offer patients whose procedures were cancelled the opportunity to 
attend a consultation to discuss this.  Before the audit, the mean waiting time was 76.8 days; 
following the audit and its recommendations, this was reduced to 56 days.   
 
In another studyxxxvii, a survey of ACPGBI and BSG members to assess knowledge of current 
guidance, showed that whilst clinicians were confident of their knowledge - for example 
39.8% recalled the criteria for the surveillance of colonic polyps correctly and 53.5% assessed 
family risk correctly - 46.5% would recommend 5-yearly colonoscopies for familial risk 
whereas the guidance suggests a single colonoscopy at age 35 and a further colonoscopy at 
age 55. 
 
The evidence does suggest a potential risk that awareness of national guidance is not optimal 
and this may result in unnecessary procedures which, as well as being unpleasant for patients, 
can present unnecessary risk. For endoscopy services, there are risks of avoidable costs and 
the impact on waiting lists as well as the opportunity costs of delays in diagnosing urgent 
cases.   
 
The National Bowel Cancer Screening Programme 
As would be expected, evaluations of the National Bowel Cancer Screening Programme 
show an increase in demand for endoscopy tests.  The evaluation of the pilotxxxviii noted the 
impact on workload and capacity, recommending that an examination of existing activity and 
capacity would be required to manage the impact of the rollout of national screening.  The 
second round evaluationxxxix noted an increase in endoscopy workload of 14% in one hospital 
and 28% at a second hospital.  Alongside the additional screening activity, increased demand 
for non-screening colonoscopies has been observed; there are also reported variations in 
waiting times for screening and elective patients, with elective patients having to wait longer 
for tests.  In addition to the direct impact on endoscopy services, workload unsurprisingly 
increased in pathology and radiology servicesxl.   
Bowel Cancer UKxli discusses the impact of changes to the bowel screening programme on 
endoscopy services, quoting a Department of Health estimate in 2011 to expect a 10-15% year 
on year increase in demand for endoscopies.  This translates into 110 extra clinical sessions 
for a medium Trust (a clinical session is defined as 4 hours typically comprising 10-12 units6 of 
activity).  It was estimated that the number of endoscopy rooms would need to increase from 
                                                        
6
 A point is a unit of time approximately equal to 18 minutes. 
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620 to 670 by 2015.  It was also suggested that demand and capacity should be considered in 
the context of waiting list initiatives, NHS reforms, Quality, Innovation, Productivity and 
Prevention (QIPP) efficiency schemes and the lack of capital spend budgets. The impact of 
increased demand affects patients, not only directly, through delays in diagnosis but through 
the bottlenecks created in the system, which affect patients’ flow.  The impact is felt by 
patients on the 2-week pathway, on the standard waiting list and on surveillance lists. 
The increased demand from the national screening programme seems to be reflected in 
other countries with national programmes, although there are differences in uptake and the 
extent of the impact; for example, in Italyxlii, the rollout of a screening programme increased 
colonoscopy activity over a five year period by 118% and increased demand in laboratory 
services for FOBT testing by 40%; in the Netherlandsxliii, the number of colonoscopies 
increased by 46% over a five year period whereas the number of endoscopists had risen by 
only 4.6%.  Across Europe, there are moves to establish further national screening 
programmes and to establish a joint committee to oversee implementationxliv. 
The uptake of the bowel cancer screening programme in England is comparable to 
colorectal cancer screening programmes in other countriesxlv; in 2014/15, overall uptake for 
FOBT bowel screening was around 58%. However, uptake for bowel cancer screening is 
lower than for other screening programmes and there is a commitment to address this  - for 
example, the evaluation of the third round  of the programmexlvi suggests that it is possible to 
convert up to 10% of non-responders, through repeated invitations.   
In the UK, the ASCEND study7 is exploring strategies to reduce the social gradient in bowel 
cancer screening.  Funded by the National Institute for Health Research, the study is a 
collaboration between University College London, Imperial College London, Queen Mary's 
University London and all five screening hubs in England. The study is testing four 
interventions in randomised controlled trials: the 'Essentials' leaflet, providing information 
about bowel cancer screening; the 'People's Stories' leaflet, which shares patient stories; a GP 
endorsement with the current invitation letter; and a revised reminder letter.   
There is evidence of lower uptake in low socioeconomic groups; one study suggests more 
needs to be done to address uptake to avoid increasing health inequalitiesxlvii. However, there 
are some regional differences – for example, higher uptake in the North of England – which 
cannot be explained solely by variations in deprivation.  Uptake tends to be higher in women 
than men and it is suggested this may be due to greater familiarity with screening, through 
cervical and breast screening programmes.  An evaluation of the uptake of the screening 
pilotxlviii found low uptake of FOBT testing and low uptake of colonoscopy for individuals from 
ethnic groups. There have been experimentsxlix (in the US) to offer colorectal screening 
alongside mammography screening for women as a way of expanding uptake among ethnic 
minority groups.  
The National Bowel Cancer Screening Programme has run awareness campaigns to 
encourage uptake of screening and the National Screening Committee has commissioned an 
evidence review into best practice to increase uptake, which will report by the end of 2015.  
National awareness campaigns 
The National Awareness and Early Diagnosis (NAEDI) Be Clear on Cancer (BCoC) campaigns - 
which aim to increase symptom awareness and presentation among members of the public - 
                                                        
7
 http://www.ucl.ac.uk/dahr/research-pages/ascend 
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have also resulted in increased activity. The bowel campaign ran nationally twice in 2012 and 
an oesophageal campaign which has the potential to drive up demand for upper GI 
endoscopy ran in 2015. The evaluation of this campaign is underway. An evaluation of the 
pilot bowel awareness campaignl showed an increase in elective waiting lists for colonoscopy 
in the East and South West Strategic Health Authorities (pilot sites) during February and March 
2011.  The analysis shows an increase in activity to respond to increased demand in March; 
however, as activity levels could not be sustained, there was an impact on waiting lists.  
Alongside the increase in the number of procedures, the evaluation estimates an increase in 
adverse events, estimating an increase of 5-6 bowel perforations as a result of the additional 
colonoscopy activity, from February to June 2011, compared to the same period in 2010.   
A comparative analysisli  in the University Hospitals Coventry and Warwickshire NHS Trust 
measured impact before (February to July 2011) and after (February to July 2012) the national 
Be Clear on Cancer bowel awareness campaign. The number of 2-week wait referrals 
increased by 47% (from 882 before the campaign to 1297 after the campaign).  There was a 
6.5% increase in the uptake of screening and a 62.5% (from 17 to 9) decrease in the number of 
patients with colorectal cancer presenting as an emergency.   
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2. Modelling Potential Changes in Gastro-Intestinal 
Endoscopy Activity in England between 2013/14 
and 2019/20 
 
Background to the model 
 
The primary objective of the analysis is to estimate the levels of activity required to meet 
demand for NHS commissioned gastro-intestinal endoscopy services in 2019/20.  The 
analysis also aims to identify and quantify the contribution of key drivers to demand growth 
and to describe any variation in demand growth by test type, purpose (screening, 
symptomatic and surveillance) and medical condition. 
 
The model focuses on diagnostic and therapeutic endoscopy of the gastro-intestinal tract 
commissioned for adults by the NHS in England.  The model is extended to include barium 
enema8 and CT colonoscopy.  Independent sector activity is included only where it is 
commissioned by the NHS.  Endoscopies of the hepato-pancreato-biliary (HPB) system are 
also included. 
 
Although waiting time data (DM01 statistics) suggests that supply side factors constrain 
endoscopy activity, the model assumes no supply-side constraints to allow conclusions to be 
drawn about the level of staffing and infrastructures required to meet demand. 
 
A detailed account of the methodology used can be found in Appendix 1.  
 
2.1 Model Results 
 
Baseline activity estimates – 2013/14 
 
We estimate that the NHS commissioned approximately 1.7 million GI endoscopy procedures 
in 2013/14.  The vast majority of these procedures (1.37m) were conducted because patients 
were exhibiting specific symptoms requiring either diagnosis or treatment.  A further 260 
                                                        
8
 Although not a form of endoscopy, barium enema activity is included in the model to allow for 
estimates of the impact of anticipated decommissioning of this activity in favour of lower GI 
endoscopy or CT colonoscopy. 
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thousand endoscopies were carried out as part of surveillance programmes.  The remaining 
60 thousand procedures were conducted as part of the bowel screening programmes. 
 
There were approximately 890 thousand lower GI, 740 thousand upper GI and 60 thousand 
HPB endoscopies conducted in 2012/13.  Of the lower GI procedures, colonoscopy was the 
most common (c. 530k) followed by flexible sigmoidoscopy (c. 300k), CT colonoscopy (c. 
60k) and barium enema (c. 2k).  Approximately 6 thousand of the upper GI procedures and 10 
thousand of the HPB procedures used endoscopic ultra-sonography.   
 
 
Figure 2: GI Endoscopy Activity by type 
 
Forecast activity estimates – 2019/20 
 
The model (See Fig 3) forecasts that by 2019/20, the demand for GI endoscopy will exceed 
2.4 million procedures per annum.  This represents a growth of 44% over the baseline 
position and a growth rate of 6.5% per annum, substantially greater than historical growth 
rates in DM01 GI endoscopy activity (2.8% per annum between 2006/7 and 2013/14). 
 
The model suggests that approximately one quarter of the forecast growth (c. 1.5% per 
annum) arise as a function of changes in demography and population health status; factors 
that might be considered to be outside of the immediate control of the health system.  The 
remaining growth is driven by deliberate strategies to improve population health or through 
the roll-out of new technologies.  The single largest contributor or growth in endoscopy 
activity is the roll-out of the bowel scope programme. 
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Figure 3: Modelled Changes in Endoscopy Activity 2013/14 to 2019/20 (figures in thousands) 
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   2013/14         2019/20 
 
 
Figure 4: Change in GI Endoscopy Activity by Site and Cohort 
  
Figure 5: Factors influencing growth in GI endoscopy activity by cohort and procedure type (figures shown in thousands) 
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Activity Changes Subgroup Analysis 
 
Lower GI activity is expected to grow at a faster rate than upper GI & HPB activity (69% and 19% respectively), with flexible sigmoidoscopy, 
colonoscopy and CT colonoscopy growing by 123%, 30% and 149% respectively between 2013/14 and 2019/20.  Forms of upper GI and HPB 
endoscopy are expected to grow by between 15% and 20%.   
 
Although symptomatic endoscopies remain the most common, screening initiated endoscopies are anticipated to grow at the fastest rate; from 
c. 60,000 procedures in 2013/14 to c. 330,000 procedures in 2019/20 (see Fig 3).  This growth in screening also serves to increase surveillance 
endoscopies. 
 
In the 2013/14 the age group generating the greatest demand for endoscopies is 60-69 year olds (See Fig 6 below).  By 2019/20, 50-59 years 
olds generate the greatest demand (as a result of the roll-out of the bowel scope programme), followed by 70-79 years olds (as a result of the 
aging population and the increased availability of CT colonoscopy). 
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Figure 6: GI Endoscopy activity in 2013/14 and 2019/20 by procedure type, cohort, age and gender (figures shown in 
thousands) 
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Sub-national Geographical Analysis 
 
Absolute variation in activity rates by CCG in 2013/14 is greater for lower GI endoscopies than for upper GI & HPB endoscopies, although relative 
rates of variation are similar9 (See Fig 7).  By 2019/20 the model suggests that variation between CCGs will have reduced10, most notably for lower 
GI endoscopy. 
 
Growth rates for lower GI endoscopies between 2013/14 and 2019/20 are expected to be particularly high in certain parts of the East Midlands 
and London. 
 
                                                        
9
 Coefficient of variation 2013/14 : Lower GI 0.23; Upper GI & HPB 0.23 
10
 Coefficient of variation 2019/20 : Lower GI 0.18; Upper GI & HPB 0.22 
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Figure 7: Modelled changes in endoscopy activity by CCG between 2013/14 and 2019/20 
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Figure 8: Geographical variation: lower GI endoscopy rates 
26 
 
 
Figure 9: Geographical variation: upper GI and HPB endoscopy rates
                                                                                                                                               
 
Other Considerations 
 
This model provides an estimate of the growth in GI endoscopy between 2013/14 and 
2019/20 based on a range of agreed change factors.  The model suggests moderate growth 
in demand for upper GI and HPB endoscopies and substantial growth in lower GI 
endoscopies. 
 
Change Factors Not Addressed within the Model 
 
The reliability of these growth forecasts is in part a function of the accuracy of the baseline 
activity estimates and of the quality of the data, methods, evidence and opinion used to 
represent the agreed change factors.   These are set out in full in Appendix 1 and can be 
assessed transparently.  However, the absence of potential change factors may also influence 
the reliability of the growth forecasts. We highlight seven potential change factors below and 
we encourage the reader to consider the likelihood of these factors when considering the 
model results. 
 
Table 2 – Change factors not addressed within the model 
 
Changes in 
patient 
expectations 
It is often reported that patient’s expectations of the NHS are rising.  Direct 
measurement of this effect is difficult and data on trends in patient expectations is 
limited.    
Patient self-
referral  
The notion of patient self-referral was raised during initial scoping meetings for the 
demand model.  This term is used to describe a scenario in which patients could 
refer themselves directly to secondary care for an endoscopy without the sanction 
of a GP or consultant.  We could find little published evidence of the impact of this 
strategy on endoscopy referral rates in the UK or elsewhere. 
Supply side 
constraints 
The model estimate changes in demand rather than activity, assuming in effect that 
supply-side factors will not constrain activity.  Simplistically, one might expect 
supply-side constraints to result in increases in waiting lists.  It is possible however, 
that supply-side constraints might influence demand-side factors. 
Technological 
advances 
The model considers the impact of decommissioning barium enema activity and 
the wider roll-out of CT colonoscopies.  Other technological advances such as the 
increased use of genomics are likely although the impact of these factors over the 
time horizon of the model is debatable. 
Substantial 
changes in 
modifiable risk 
factor 
prevalence 
The model assumes some marginal change in age-specific incidence of cancer 
and Barrett’s oesophagus based on historical trends.  Inherent within this approach 
is an assumption that trends in modifiable risk factors (e.g. smoking prevalence, 
obesity etc.) will continue on their current trajectory.  Any substantial change in risk 
factor prevalence will have an impact on disease incidence and prevalence 
although it is likely that the lagged impact of any such changes will be negligible 
over the time horizon of the model. 
Screening 
impact on 
symptomatic 
referrals 
Whilst the model estimates the impact of screening on surveillance activity, it 
makes no assumption about the impact of screening on symptomatic activity.  If 
effective and if uptake is high, one might reasonably expect screening activity to 
lead to a reduction in symptomatic referrals and emergency endoscopies. 
Estimating the scale and lag of such an effect would not be trivial. 
Other 
population / 
demographic  / 
social effects 
Whilst the model assumes changes in population size, age/gender profile and 
health status, no assumption are made about changes in the population structure 
by other factors such as ethnicity, migration status and deprivation.  Estimating the 
future population structure in these terms or indeed estimating the influence of any 
such changes on demand for endoscopy is not straightforward.  
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Other Models of Future Endoscopy Demand / Activity 
 
A number of other models of future endoscopy activity or demand were considered prior to 
or during the design and implementation of the demand model for this report.  Whilst the 
objectives, scope, focus, and time horizons for these models differ, the high level conclusion 
is consistent; i.e. substantial growth in demand over the medium term for lower GI 
endoscopies and moderate growth in upper GI endoscopies  
 
Table 3 – Other activity and demand models considered 
 
Model Objective 
Department of Health - 
Lower GI Endoscopic 
Activity Forecast (2011) 
This national model was designed to explore the commitments 
in the Cancer Strategy, expansion of the screening programme   
and underlying pressures on lower GI endoscopic activity up to 
2016/17. 
Anglia Cancer Network - 
Endoscopy Demand 
Forecast Models (2012) 
These models were designed and built in order to assist Trusts 
and Commissioners in the Anglia Cancer Network to plan for 
the delivery of endoscopy procedures up to and including 
2016/17, taking into account known central initiatives to increase 
or extend routine bowel screening, as well as local aims to 
reduce variations in practice across the network. 
Wessex AHSN and 
Strategic Clinical 
Network (2014/15) 
Using skills from a number of academic disciplines 
(population demography, geographic mapping, 
mathematical modelling and management science) this group 
are studying the impact of introducing the bowel scope test into 
the screening programme to support hospitals and 
commissioning area plan service effectively 
NHS England – 
Endoscopy Modelling 
(2015) 
The aim of this work was to produce a summary of current 
trends in endoscopy capacity and waiting times, delivery against 
the commitment to deliver 99% of diagnostic tests within 6 
weeks, and to project the future situation should no action be 
taken. 
CCG Activity Modelling - 
London Endoscopy 
Strategy (2015) 
The Transforming Cancer Services Team for London developed 
an activity and costing model for CCGs based on the roll out of 
the Best Practice Commissioning Straight to Test Pathway over 
two years for the low risk, not no risk patient group. 
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3. Findings and recommendations 
 
3.1 Meeting rising demand 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background 
As mentioned above, demand for endoscopy services is rising sharply for a number of 
reasons. The NHS will be expected to deliver more than 750,000 more endoscopies per year 
by 2020, and steps must be taken now to ensure services are equipped to cope with this 
rising demand so they can deliver the best care and that patients receive their diagnosis and 
treatment in a timely manner.  
 
Findings 
Though many units talked of the steps they had already taken to respond to rising demand 
such as increasing their physical space and recruiting additional staff, the overriding 
impression from interviewees and survey respondents is of a service under increasing 
pressure.  
 
‘And so it very much feels like we’re sort of full to bursting at the moment and people 
are doing lots of things to try and keep on top of things’- National interviewee 
 
This pressure was apparent to the research team when trying to schedule interviews. Though 
individuals and units expressed a real interest in the project when they were contacted and 
invited to take part, many were unable to do so as a result of service pressures. Units are 
therefore just about coping, or ‘keeping their heads above water’ as one interviewee put it. 
 
For units to cope with rising demand within the waiting times determined by current targets, 
this has often meant putting on regular waiting list initiative sessions at weekends and in the 
evenings, or bringing in external staff through companies that provide such services. These 
arrangements come with attendant additional costs which are ultimately unsustainable.  
 
‘Up until last September … we were running with waiting lists initiatives for 
consultants on an ongoing basis.  We also had actually asked Medinet to come in. 
But there is a significant cost to that. …But this summer because I've employed a 
locum endoscopist and I've got my Nurse Endoscopists, … for the first time ever our 
waiting times without any extra waiting list sessions are within our normal workforce 
really.’ – Service line manager 
Recommendations 
• The Government should increase investment in diagnostic services, as set 
out in Achieving World-Class Cancer Outcomes, to ensure the NHS can 
meet rising demand and that our cancer outcomes become the best in 
the world. This should include a dedicated £125 million diagnostics fund 
over five years. For endoscopy specifically, investment will be needed to 
recruit and train new members of the workforce and replace ageing 
equipment. 
• NHS England and Public Health England should ensure learnings from the 
bowel screening programme are applied across the symptomatic pathway 
so there is not a two-tier system and patients receive a consistently high 
level of care regardless of their route into the health system. 
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It is also unrealistic to expect existing staff to work additional hours on a regular basis to cover 
weekend and evening lists.  
 
‘There’ll be some Saturdays when we don’t get anybody. I would say the consultants 
are very reluctant to because they’re exhausted after a full week.’ - 
Gastroentorologist 
 
It is worth noting that the JAG timeliness scores11 as reported in April 2015 appear to have 
reduced significantly from those reported in April 2014. At that point, 78% of units were 
scoring an ‘A’ grade for timeliness – this has reduced to just 60% of units in the April 2015 
census.  
 
 
Awareness campaigns 
The impact of the cancer awareness campaigns has been felt quite strongly by many units 
that responded to the survey, and as reported by interviewees. One unit noted that they were 
receiving about 22 urgent Upper GI referrals a day as a result of the campaign but were only 
able to undertake 18 such procedures in a day, so their lists were continually growing.  
 
‘We knew it was coming, we were given a few weeks’ warning, but it was just at the 
wrong time of the year, January is always manic because everybody’s overindulged 
in December, so it’s always a very, very busy month and also it’s flu season as well, 
but our 2 week referrals doubled, so we had to put on quite a lot of extra lists to help 
and we've also outsourced to the ISTC as well to help deal with the capacity.’ – Lead 
endoscopy nurse 
 
A number of clinicians questioned the pick-up rate through the two week referrals driven by 
awareness campaigns. 
 
The bowel cancer NAEDI produced nothing in terms of increasing cancer diagnosis 
… but it created a …blip and then a sustained rise in the demand for colonoscopy as a 
result ...  data from my own organisation (shows)… the ever-inexorable increase in 
two-week-rule referrals, with a lovely upslope over five years, consistently, and an 
absolute flat line in the number of cancers diagnosed. – National interviewee 
 
Several interviewees suggested investment should be in bowel screening awareness instead 
of symptom awareness campaigns as they thought the pick-up rate would be better and it 
would deliver better value for money.  
 
The Bowel Cancer Screening Programme 
The BCSP is seen as promoting best practice and improving quality and there are different 
operating standards and time-to-treatment targets for those individuals with positive test 
results than for symptomatic patients coming through other pathways. It was described as the 
‘gold standard’ by a number of those people we interviewed.  
 
                                                        
11
 A JAG timeliness score of A means that a unit is self-reporting that it is answering yes to all measures 
relating to timeliness, this includes managing to keep waits below two weeks for urgent procedures 
and six weeks for routine procedures  
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‘From the bowel cancer screening programme point of view, the way the patients 
are managed; the way the numbers are limited on the list is superior to our normal 
list.’ – Nurse Endoscopist 
 
Participants are given a ‘key worker’, or ‘case manager’ – known as a specialist screening 
practitioner who guides participants through the whole process and provides continuity of 
support and advice. It is likely that this kind of support is a major factor in achieving non-
attendance rates on the Screening Programme which are much lower than for non-
screening procedures – a mean of 0.3% compared to 4.6% for standard activity12. However, it 
comes with an attendant cost in terms of resource. Currently the cost of screening activity is 
covered by Public Health England. The symptomatic pathway could learn from the success 
of the screening pathway to reduce non-attendance rates. 
 
Bookings for the screening programme and instructions and arrangements for bowel 
preparation are made from the screening hubs and this can cause some difficulties for units 
as communication is not within their control. For example, in order to ensure slots are not left 
empty, the screening hubs may overbook available slots.  This means that on occasions more 
people might attend than had been anticipated and people are required to re-book. It is 
possible that this will have a detrimental effect on future attendance. 
 
The NHS Bowel Cancer Screening Programme began piloting the flexi-sigmoidoscopy (flexi-
sig) test, or bowel scope in 2013 and roll out is now in its second phase. Though geographical 
coverage may be on schedule, absolute capacity is not, as units enrolled in the programme 
have not yet established their full complement of lists. Endoscopists have to be specifically 
accredited in order to undertake bowel scope screening, and the process for achieving this is 
perceived as logistically onerous. A number of medical endoscopists that were interviewed 
suggested that the nature of the work is not seen as particularly stimulating because there are 
strict limitations on what can be done during the procedure in terms of therapeutic 
interventions. They also suggested that the polyp deduction rate (in BSS) is also lower than 
anticipated.  
 
A number of interviewees and survey respondents alike commented that the screening work 
reduces the symptomatic and surveillance service capacity and puts pressure on diagnostic 
services.   
 
‘The screening service operates to a higher standard than the symptomatic service 
and I think that can make life very difficult for the providers having to carve out 
resource as well for screening patients which isn’t a very efficient way of working.’ – 
National interviewee 
 
In some areas, there is a high degree of co-ordination and flexibility between the screening 
and non-screening services so that lists can be re-allocated if needed between the two. 
 
‘We are constantly in communication with the endoscopy waiting list managers so 
that if we have an increase in numbers coming through, we try and take any dropped 
lists off them so … we can use those lists, …, and similarly if we've got lists that are 
empty then we would try and hand them back in a timely fashion so that the 
endoscopy department can use our screening time for their symptomatic lists so 
                                                        
12
 Figures calculated from JAG April 2015 GRS census returns 
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that everybody’s trying to keep on top the waiting times and the waiting lists.’ – Lead 
specialist screening practitioner 
 
However, there were also reports of staff being reluctant to provide cross-cover across the 
two activities. 
 
‘When screening first started the clinicians were very keen to cross cover.  Being part 
of a national screening programme was quite prestigious and motivation was very 
high … we don’t get the willingness to cross cover (now)...  and that’s probably 
because of the pressures within the symptomatic service. – Lead specialist screening 
practitioner 
 
The introduction of bowel scope lists in some units, and the increase in demand from two 
week wait referrals in response to the recent Upper GI awareness campaign have meant that 
either more lists have had to be found at weekends and in the evenings, or existing lists are 
being squeezed. In some instances this means that training lists are being compromised. 
There is also concern that quality will be compromised too.  
 
‘We’ve got to think about the future and … I struggle to work out where I can put 
people to train ... when people need to be trained they need to have at least one 
dedicated list, and right now I think we’re just squeezing in people where we can 
rather than dedicated lists, and that’s my biggest worry.’– Clinical lead 
 
‘Between 2% and 12% of people are having their cancer missed or not prevented and 
the figures for upper GI cancer are about 93%/94% so 6% of 7% of people are having 
a cancer diagnosed six months to a year later after a negative endoscopy.  And the 
reason is that people aren't doing endoscopies properly and if you flood the system 
with more endoscopies you'll just have more bad endoscopies done and more 
cancer missed.’ – National interviewee 
 
Complexity of procedures and non-endoscopic activity 
In general, it appears that developments in technology and changes in practice have led to an 
increase in more complex procedures being undertaken within endoscopy units.  
 
‘We seem to be doing a lot more ERCPs13, the demand for ERCPs has increased.  
We’re doing a lot more ESDs14, EMRs15, we’re just taking on halo16 lists as well, so it 
just seems that gradually the demand is increasing.  We also do EUSs17 within the 
department as well, …when it was originally introduced it was only going to be a 
certain amount and it’s double or tripled since then.’ – Lead endoscopy nurse 
 
‘Some of our consultants now are doing a lot more therapeutic work. These are 
patients that would normally have gone through major bowel surgery…and they're 
now having significant removal of the polyps, … within the endoscopy department … 
But what happens … is (we )go from the 13 point list where we might have on 
                                                        
13
 Endoscopic Retrograde Cholangiopancreatography 
14
 Endoscopic submucosal dissection 
15
 Endoscopic mucosal dissection 
16
 The endoscopic ablation of Barretts oesophagus using radiofrequency ablation (RFA) 
(HALO®system) 
17
 Endoscopic ultrasound 
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average about eight patients on it, to … one patient. So it’s a significant demand on 
the service.’ – Service line manager 
 
This is affecting not just GI endoscopy activity but also the other procedures that units might 
be undertaking and which ultimately have an impact on their capacity.   
 
‘When Bronchoscopy was being used inefficiently we reduced one of the 
Bronchoscopy lists but their demand has increased again recently and they’re doing 
EBUS as well and want some more capacity.’ – National interviewee   
 
The Independent Sector 
It appears from this study that the NHS is using the Independent Sector in a relatively ad hoc 
way, drawing on its capacity when necessary, rather than working in a more systematic and 
planned way. For example, independent units report ‘mopping up’ activity from the NHS, such 
as non-urgent referrals when their local NHS unit is under pressure. There are some examples 
of CCGs systematically commissioning services such as non-urgent referrals from alternative 
providers but this is not necessarily a widespread practice across the country.  
 
‘We’d have splurges of putting everything out to the private sector because we were 
at risk of breaching then there would be this big panic … then things would settle 
down again and we’d be fine for another year … why not smooth those peaks and 
troughs by having some sort of arrangement with your private provider where you 
can just filter stuff through on a fairly regular basis?’ - National interviewee 
 
Where non-NHS providers are delivering services, or where NHS community providers are 
involved, robust mechanisms for routing people into the relevant MDT18 must be established. 
A number of examples where this was happening effectively were described to the study 
team but there are still concerns among NHS acute providers regarding the quality of 
independent and community providers and their ability to manage patients appropriately and 
work within integrated pathways with other providers. 
 
‘There are times when you have to use private providers. There are several caveats 
though. First of all, they have to meet the same quality assurance standards as the 
NHS services. So they would have to have JAG accreditation. Secondly, they have to 
be appropriately linked up…there has to be a very effective and just as prompt 
feedback to the GP and the patient as there is in the NHS.’ – National interviewee  
 
The issue of NHS endoscopists undertaking private practice was raised a number of times by 
interviewees. Concerns were raised about medical endoscopists being lukewarm towards 
non-medical endoscopists out of a desire to ‘protect’ their private practice, and about the lack 
of incentives for medical endoscopists to perform efficiently in the NHS. 
 
‘…one has to recognise that there are perverse incentives in terms of Consultant 
Endoscopists. The Consultant who perhaps isn’t terribly efficient at running his list in 
the NHS may well be the same Consultant who is doing the same cases down the 
road in the private sector and private endoscopy is extremely well paid.’ – National 
interviewee  
 
                                                        
18
 Multi-disciplinary team meeting to discuss diagnosis and treatment of cancer patients 
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‘… they would be putting on lists at the weekend and paying endoscopists huge 
amounts of money and the nurse huge amounts of money to do a waiting list 
initiative when in actual fact their lists in the week weren't even properly filled or 
utilised …’ – National interviewee 
 
These are the perceptions of interviewees and it was not within the scope of this piece of 
work to determine whether there is any correlation between private practice or waiting list 
initiative activity and performance against standard NHS lists.  
 
It is also worth emphasising that the systematic use of other facilities, whether independent or 
not, for non-urgent diagnostic work removes the simple, fast, and ‘cheap’ procedures from 
the main facility. Resource use per procedure in the latter would consequently rise and 
therefore across the system as a whole, significant savings are unlikely to be realised, though 
patient experience may be enhanced by shorter waiting times and a more patient-friendly 
environment.  
 
Community provision and centralisation 
The current strategy document for the NHS – the Five Year Forward Viewlii sets out a number 
of potential new models of care, one of which is the Multi-speciality Community Provider 
which would see groups of GPs coming together to create much larger practices providing 
an enhanced range of services such as diagnostic tests and procedures. It is suggested that 
these kinds of providers could shift the majority of outpatient-type activity out of hospital 
settings.  Certainly, the consensus of opinion from those interviewed suggests that routine 
diagnostic work could be done safely within the community.  
 
‘…in terms of productivity there is something about moving it out of the hands of 
Consultants as far as the basic diagnostic tests are concerned and moving it into the 
hands of technicians. … the majority of diagnostic endoscopy, not therapeutic, but 
diagnostic, should take place in community based centres …an industrial approach.’ 
– National interviewee 
 
However, this transfer of activity would require a careful consideration of the risks involved 
and significant investment in infrastructure and staff – the decontamination equipment alone 
is seen as being prohibitively expensive and staff shortages would be no less of an issue in the 
community than they are in the acute sector, so this may not be a cost-effective approach.   
 
‘If you were just doing a diagnostic colonoscopy in a fit patient I have no problem 
with that happening in the community. If you were doing a therapeutic endoscopy 
where you’re removing a big polyp, there’s small risk of perforating the bowel, it’s a 
very high risk patient. It’s going to need to be in the hospital setting.’ – National 
interviewee 
 
‘We run our facility with our four rooms running where we continuously clean and 
decontaminate the scopes through our decontamination area.  So we haven’t got 
enough endoscopy scopes to be able to run every list without reprocessing the 
scopes and cleaning them…if we needed to have an offsite facility …we would have 
to purchase around an extra 30 or 40 scopes, because we wouldn’t provide a 
decontamination area offsite which has significant costs associated with it …you 
would be very limited what type of procedures you could move offsite because of 
the risk factor.  So obviously no patients for sedation, no patients with high mortality… 
And you would need to employ more staff.’ – Service line manager 
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It was suggested that though the reconfiguration of services would be a matter for local 
health economies to determine, national leadership could help with planning by setting out 
criteria for what could safely, effectively and cost-effectively be delivered in the community.   
 
‘We could do a lot more in the community and take it closer to patients...  we could 
stratify out better our two week wait urgent things from our non-urgent, less likely to 
need a biopsy work, and I do think we could deliver things in a community setting 
much more effectively … you need national leadership and strategy and direction 
and then you need the systems and leaders in place to enable that to be delivered at 
a local level.’ – National interviewee 
 
Again, the removal of high volume low-cost procedures from acute units may not allow any 
resource saving across the system as a whole, as it would consequently raise the cost of the 
remaining procedures in the acute sector. Increasing community provision remains an option 
however if physical space within the acute sector is the underlying problem. 
 
The view was also expressed that it might be desirable to consider centralising some 
procedures like ERCP in ‘expert’ units, so that resources are rationalised and clinical 
competence and quality are more easily maintained. Any wholesale reconfiguration of 
endoscopy services should be down to local health economies to determine and it is 
possible there is little appetite for this given the range of other priorities they need to address. 
Clinical Networks could take a role in these discussions but there was little evidence from the 
study that they were doing so.  
 
Summary 
In summary, services are clearly feeling the pressure of rising demand and will require 
considerable support to cope with it in the years to come.  
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3.2 Workforce 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background 
When asked to comment on the biggest barriers for units in managing demand, the most 
common response among survey respondents was staffing issues, with space and 
infrastructure issues as the second biggest barrier. Physical capacity has increased 
considerably in recent years (according to the responding acute trusts19 from the JAG data set 
there are currently 658 rooms within the acute sector) and though there are some issues 
mentioned in specific areas about a lack of physical space, increasing physical capacity would 
need to be matched by increasing the workforce.20  
 
Findings 
Recruitment 
There has been a great deal of recruitment activity happening within endoscopy services over 
the last 12 months in order to increase capacity but in spite of this, staffing issues appear to be 
a limiting factor for many units, according to our survey respondents and interviewees. These 
relate to the recruitment of Consultant Gastroenterologists21, non-medical endoscopists and 
                                                        
19
 203 from a possible 221 which suggests an average total of 716 rooms 
20
 HEE was contacted to contribute to this report, but it was not possible to secure an interview, which 
means a key perspective on workforce issues is missing.  
21
 According to the BSG Workforce Report (2015), there were 1,370 substantive Consultant 
Gastroenterologists in the UK on 1
st
 June 2015. The report notes a third of advertised consultant posts 
are not filled, though there are 110 UK CCT holders without a substantive consultant post. In 2011 the 
RCP calculated that the actual number of consultants required to serve the population of England and 
Wales was 1516 (1584 when part-time consultants are taken into account). However, the 2011 figures 
do not take into account major service changes such as the introduction of bowel scope and 7 day 
working, so a further expansion in posts is required. 
Recommendations 
• Strategic planning around workforce should happen at the national level 
as recommended in Achieving World-Class Cancer Outcomes. We are 
aware that Health Education England is working with NHS England to 
deliver a training and development programme for Nurse Endoscopists, 
but this work should also include a robust assessment to determine the 
required number of trainees based on rising demand. Similar steps should 
be taken to ascertain the required level of new Consultant 
Gastroenterologists, Consultant GI Surgeons, other non-medical 
endoscopists, and Senior Endoscopy Nurses. 
• Commissioners should work with local services to ensure the protection 
of training lists so that staff are adequately trained.  
• Leadership teams should ensure the unwarranted variation between units 
in Nurse Endoscopists’ pay is eliminated.  
• NHS England and the Department of Health should work to ensure all staff 
involved in the delivery of endoscopy services are prepared for the 
transition to 7-day working. This should involve the management of 
expectations from the recruitment stage, and the provision of appropriate 
compensation. In addition, local services should ensure job plans are 
appropriately balanced to encourage retention and avoid burn out. 
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senior endoscopy nurses, and the retention of Nurse Endoscopists specifically. A number of 
units mentioned that they had re-advertised posts for consultant gastroenterologists, Nurse 
Endoscopists and endoscopy nurses several times over before they could fill them and in 
some cases, posts remained unfilled.  
 
‘We went out to advert for qualified Nurse Endoscopists and it took three attempts 
before I was able to get anybody who'd had any previous experience.’  – Service line 
manager 
 
‘It’s proving to be very difficult to recruit to the Nurse Endoscopist role… xxxx in 
particular have had adverts in circulation for a long time, and they haven’t been able 
to secure anybody either in a training post or as a qualified Nurse Endoscopist. 
Despite offering attractive grades, there is just nobody being recruited to the post.’   – 
Lead specialist screening practitioner 
 
It appears from the survey respondents that Band 5 nurses are particularly difficult to recruit. 
One unit reported that it had gone out to advert seven times for Band 5 nurses while another 
reported that it had taken 12 months to recruit two Band 5 nurses. Recruiting nurses with 
endoscopy experience is difficult though there appears to be interest from nurses without 
endoscopy experience. This means that units are required to undertake in-house training of 
these new recruits which will inevitably have an impact on their ability to work to optimum 
capacity.  
 
Some units have gone overseas to recruit nurses while others have set up open days in the 
unit to boost interest and have had student nurse placements to encourage an interest in the 
service. According to the responses to the JAG survey conducted for this study, the vacancy 
rate is running at an average of close to 10% for qualified nursing staff.  
 
The role of the Nurse Endoscopist 
The in-house training of nurses already working in endoscopy settings as Nurse Endoscopists 
has been seen in the past as a pragmatic solution to resourcing issues but there are a number 
of factors that suggest Nurse Endoscopists are by no means a panacea for the staffing 
problem. A recent reviewliii points to a range of studies which demonstrate Nurse 
Endoscopists are as effective as medical endoscopists, including undertaking newer 
techniques such as capsule endoscopy. The cost effectiveness of nurse versus medical 
endoscopists is less clear.  Studies assessing cost per test suggest Nurse Endoscopists can be 
more cost effective. However, a studyliv, using QALY as a measure of cost effectiveness, 
suggests medical endoscopists offer additional value through reduced follow up or 
attendance in primary care, possibly due to their ability to offer advice and guidance to 
patients during the endoscopy.   
 
Patient satisfaction is often reported to be higher for Nurse Endoscopists, possibly due to the 
time spent with patients or their role as patient advocateslv. Findings in Scotlandlvi have 
demonstrated the ‘added value’ non-medical endoscopists bring to the service in enhancing 
the patient care experience. However, variations in the job activities of non-medical 
endoscopists highlight the tension between the technical and caring aspects of the role, with 
participants expressing concern around the potential to limit the practice of these 
experienced nurses to a technical function. 
 
A study also found that nurses required assistance in around a quarter of the procedures 
performed, in the form of advice, assistance with the introduction of the endoscope or with 
polypectomylvii.  A further studylviii from the Netherlands reports comparable findings. The 
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authors compared Nurse Endoscopists to physician trainees finding that while the quality and 
safety was comparable to medical endoscopists, it was acknowledged that there were 
differences in requirements for maintaining skills across the different professions. The study 
authors therefore recommended guidelines for Nurse Endoscopist training to establish 
criteria to maintain competence after initial training. 
  
A studylix exploring the experience of endoscopy nurses participating in the nurse-led Flexible 
Sigmoidoscopy Screening Pilot, found that nurses were positive about the skills development 
from their participation.  They noted some stress points which included decision making 
under pressure and coping with high throughput of patients, suggesting a potential risk that 
quality could be compromised during peaks of high demand and high complexity to ensure 
clinics run on time.  Nurse Endoscopists also expressed concern at the risk of monotony, 
suggesting that a mix of activity (e.g. screening and diagnostic) would be important to relieve 
boredom.  This was reflected in our research. 
 
‘Bowel cancer lists for the FOBT programme are very challenging examinations.  
They are finding lots of pathology … these are very interesting lists to work on.  That 
can’t be the same for the bowel scope lists.  …From a physical examination point of 
view they can be very boring and laborious I can imagine for the endoscopists 
because sometimes they're churning through a list of ten patients and they're finding 
absolutely nothing.  … So it’s a hard grind for them.’ – Lead specialist screening 
practitioner 
 
However, the same study does suggest that including an element of screening in work 
schedules may increase job satisfaction as dealing with symptomatic patients is seen as more 
stressful as patients themselves tend to be more stressed.   
 
According to interviewees, the in-house substitution of a senior member of the nursing staff 
to become a Nurse Endoscopist creates a different, and often no less problematic gap to fill.  
 
‘There are several really significant issues for nurse endoscopy.  One is that you take 
the most senior nurse out of the department and you make them into endoscopists 
and you then lose your most senior nurse and that’s a significant issue for many 
institutions.’ – National interviewee  
 
One unit had experimented with employing a number of newly qualified nurses to fill nursing 
vacancies on the unit but had seen them transfer out of the department in preference for 
ward-based posts. This had led the unit to realise they were probably too specialised an area 
for newly qualified nurses.  
 
Training and grading 
While experienced endoscopy nurses may be interested in the role of an endoscopist, the 
technical nature of the job requires candidates with the right skills and attitudes, and not all 
endoscopy nurses would make suitable Nurse Endoscopists. The training to achieve 
independent practitioner status takes approximately two years and though training to this 
level could be achieved more quickly in theory, this acceleration would inevitably result in an 
associated trade off in capacity which is problematic, in the current conditions of increasing 
demand. In fact, as reported by a number of interviewees, existing training lists are already 
being compromised.  
 
‘We’re also meant to be training up the other Nurse Endoscopists to do Flexi-sig 
[bowel scope], and at the moment with the way the lists and everything are because 
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of capacity we haven’t been able to do the training… But if we've got a full list which 
we’re now having to because of capacity … it causes more problems with the 
assessment process for them and their training’. – Nurse Endoscopist 
 
‘If you have one or at the most two nurses trying to do endoscopy in a unit alongside 
the doctors they’ll be competing in some circumstances for lists with trainees who 
are trying to get their numbers up…there will be competition between some of the 
doctors and some of the nurses on those grounds.’ – National interviewee 
 
This qualitative data is reinforced by the 2014 British Society of Gastroenterologylx medical 
trainee survey which reports that 39% of trainees in a training post had less than 1 dedicated 
training list per week on average, and that poor quality training lists are seen as a main barrier 
to endoscopy training. This is disappointing given that training in endoscopy was perceived to 
have improved following the introduction of JAG accreditation and the bowel cancer 
screening programmelxi.  For example, a 2007 audit of training in London showed significant 
improvement compared to an audit in the same patch five years earlierlxii. Effective training 
underpins good quality patient care and its importance is referenced repeatedly in the 
literature. 
 
Work is underway through Health Education England (HEE) to increase the number of training 
providers of non-medical endoscopist training modules, in order to increase the external 
capacity required for training. Work is also ongoing to develop a nationally agreed 
competency framework for these staff. 
 
There are also only a handful of providers of the academic content of training for non-
medical endoscopists, and this has an impact on the number of practitioners that can enrol at 
any one time.  
 
Once training is underway, retention of Nurse Endoscopists can be challenging for a number 
of reasons. There is some degree of variation between units as to the band at which Nurse 
Endoscopists are paid. Some of this variation can be justified – for example units might start a 
nurse at a Band 6 when training and recognise the completion of training with a re-grade to a 
Band 7. Other units have Band 8 Nurse Endoscopists, which may reflect additional clinical 
duties such as the delivery of nurse-led services and clinics. It does appear however, that 
some of the Nurse Endoscopists interviewed for the study were dissatisfied with the band at 
which their job was graded.  
 
“The bands for Nurse Endoscopists range from band six, which is a Sister’s grade 
then onto mine, which is a senior Sister’s grade and then others which are paid at like 
a Matron grade.  I think a lot of the hospitals whereby they're asking for or giving out 
a higher grade do the same sort of job is where they're having difficulty recruiting, so 
it’s almost like an incentive…” – Nurse Endoscopist 
 
The quality of clinical support provided to all non-medical endoscopists is seen as critical in 
ensuring quality standards are maintained and to promote job satisfaction but as units 
become busier and busier, such support can be stretched thin.  
 
One other area that might be worth attention is the training of GPs as endoscopists. It was 
suggested that in previous years, it was more commonplace for GPs to learn to do 
endoscopic procedures and that this is no longer the case.  It is feasible that pressure on 
training lists for gastroenterologists, surgeons and Nurse Endoscopists means that interested 
GPs are simply not able to find the means by which to develop these skills.  
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Stress and well-being among the workforce 
The physical nature of scoping can also create difficulties with some interviewees noting the 
incidence of RSI (repetitive strain injury) among colleagues who scope and the incidence of 
stress and ‘burn out’ in staff more generally.  
 
‘…when a nurse is trained and becomes very competent, she gets overworked and 
burns out.  … endoscopy is not something you can do 9 till 5, five days a week. And 
they do get used as the workhorses, and then they collapse after a while.’ – National 
interviewee  
 
‘And I sent it out saying ‘please tell me how many scopes; how many sessions do 
you do; …and the average came back that they did about four, but there were so 
many comments from those who’d been doing it ages saying ‘we used to do more 
but we ended up with RSI’ so it’s a really big problem.’ – Nurse Endoscopist 
 
Units were not asked specifically about their sickness absence rates for this study, but 
according to figures recently released by the Health and Social Care Information Centre, 
sickness absence for nursing staff is holding steady at just under 5% on average for 2014.  
 
However, it is reported that absences as a result of stress, anxiety and depression among the 
NHS workforce as a whole appear to be risinglxiii. According to these figures, staff absences for 
mental health problems in hospital trusts in England have doubled in the past four years. Data 
acquired via a freedom of information request showed that 41,112 NHS staff took sick leave 
for anxiety, stress and depression in 2014, a rise from 20,207 in 2010. One unit noted that 
from a nursing staff group of 50, sickness and maternity leave had taken out a fifth of these 
posts, leaving the unit struggling to cover the gaps. It may therefore be helpful to plot sickness 
within endoscopy units systematically to ascertain whether the trend is of increasing rates of 
sickness in those units that are under greater pressure to manage their demand.  
 
Maintaining clinical competence 
There is a large body of scientific evidence to show that fatigue affects human performance 
but little research has been undertaken to assess fatigue in the performance of endoscopy 
procedures. However practitioner fatigue is a plausible reason for colonoscopy completion 
rates reducing during successive procedureslxiv. Job plans for all endoscopists should 
therefore be balanced and should not lead to a list commitment which is overly physically 
demanding. In general, interviewees and expert opinion suggest that five to six lists per week 
should be seen as the maximum for individual practitioners.  
 
‘All the pressures that you have as a Nurse Endoscopist are hard because if you're 
doing back to back lists, especially colonoscopy, it’s really tiring mentally and 
physically, and then you're in again the next day doing it again. ..doing one session a 
day would be ideal.’ – Nurse Endoscopist 
 
‘You'd be far better off employing two or three nurses to do two or three lists a week 
and bolting on other roles to their job than just one to do six/seven lists a week, 
which isn't safe really.’ – National interviewee 
 
The need to limit lists to avoid fatigue needs to be matched by the need to ensure that all 
endoscopists perform enough procedures to maintain clinical competence. There are quality 
measures for performing endoscopic tests which provide a minimum number of procedures 
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per annum that each practitioner should achieve. For the Bowel Cancer Screening 
Programme, this is more than 150 colonoscopies a year – or one list per weeklxv.  
 
Evening and weekend lists 
A service that routinely provides weekend and evening lists is considered to be a good quality 
service as determined by the British Society of Gastroenterology’s guidance to 
commissionerslxvi.  This is set against the context of a concerted policy drive for seven day a 
week serviceslxviilxviii. The need for system change to address the issue of seven day services 
has led to the development of a set of clinical standards to be implemented across England 
by the end of 2016/17.  These standards are focused in ten areas including diagnostics22. The 
principle of seven day working is supported by a range of professional bodies, including the 
Academy of Medical Royal Collegeslxix and the Royal College of Physicianslxx.  
 
However, it was reported through interviews that some units had lost nursing staff (both 
endoscopists and non-endoscopists) because of the increasing demands placed on them to 
work ‘unsocial hours’. It was suggested that this might in part be due to family commitments, 
given that the historic pattern of working in units may have initially attracted people to work in 
endoscopy for these very reasons.  
 
‘Their assumption of what endoscopy is, is a little bit different, so they come in and 
they realise that actually although it’s a day unit, it’s not an easy day unit, it’s very hard 
work and you're on your feet all day and it’s a long shift.  And we've had three of 
them that have had to turn round and go back to the wards because of childcare 
issues and things.’ – Lead Endoscopy Nurse 
 
A reluctance to work ‘unsocial hours’ is not limited to nursing staff, as medical staff were also 
reported as being less than enthusiastic at times to cover weekend shifts.  
 
‘I mean our hours have already changed from good old 8.00 to 5.00 but it’s getting 
the endoscopist to cover the session because…why should it just be us doing the 
evenings and the Saturdays, that’s not fair… But because of our staffing issues at the 
moment we haven’t actually got the staff to cover the twilights or the Saturdays at 
the moment.’ – Nurse Endoscopist 
 
‘I'm staffed for 43 sessions per week, and that’s Monday at six days a week, because 
we work a Saturday as well, and in the future we are looking at our workforce 
planning in relation to seven day working.  And really the only reason we haven’t 
moved to seven day working is because we haven’t got the medical staff to support 
that.’– Service line manager 
 
It is important to recognise that in order to provide cover across seven days, more staff are 
required across all professional groups – it is certainly not desirable from a quality and safety 
                                                        
22
 The standard for diagnostics states: “Hospital in-patients must have scheduled seven-day access to 
diagnostic services such as x-ray, ultrasound, computerised tomography (CT), magnetic resonance 
imaging (MRI), echocardiography, endoscopy, bronchoscopy and pathology. Consultant-directed 
diagnostic tests and their reporting will be available seven days a week: within 1 hour for critical 
patients; within 12 hours for urgent patients; and within 24 hours for non-urgent patients.” 
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perspective not to have consultant cover during unsocial hours in case complications arise 
that non-medical endoscopists cannot manage independently.  
 
 ‘The perception of extended working is always we’re going to be worked harder, 
rather than explaining that actually no it’s the same amount of work but over a 
different working pattern…’ – National interviewee 
 
‘Whilst it’s all very well to say ‘yes sweat the assets we can work 24/7’ I do think it’s 
unrealistic and it’s all very well saying ‘oh well the Nurse Endoscopists can do the 
weekends and the evenings’ but we would still need to have a consultant available in 
case there was any complications ….’ – Nurse Endoscopist and endoscopy manager 
 
NHS Improving Quality (NHSIQ) was delivering a programme to support 7 day working; there 
were 13 early adopter health economieslxxi.  NHS IQ also developed a toolkit to help 
organisations implementing 7-day workinglxxii which provides a baseline assessment and 
highlights where work is needed.  Their ‘Productive Endoscopy Unit’ toolkit also aims to 
support endoscopy services to progress towards seven day working.  
 
The role of medical staff in endoscopy 
Specific challenges arise in relation to the medical staff working within an endoscopy unit. 
According to the Royal College of Physicians, approximately 60% of Consultant 
Gastroenterologists take part in their organisation’s unselected medical takelxxiii. This 
combined with other commitments such as the GI bleed rota means that there are regular 
sessions when they are unavailable for scoping. One Consultant Endoscopist interviewed for 
the study described the effect of this as the unit losing at least two lists a week when he spent 
his turn of the rota on the wards. As the number of medical admissions continues to rise 
across the NHSlxxiv this inevitably puts pressure on non-endoscopic activities such as ward 
rounds. This has a knock on effect of endoscopy PAs (programmed activities).   
 
‘One of the difficulties of leaving it in the hands of largely Consultant Physicians is 
that they have many other calls on their time. Many of them do maybe two lists a 
week or even only one list a week …’ - National interviewee 
 
‘The average highly trained colonoscopist will be doing two sessions a week. …we’ve 
got these highly skilled people ready to diagnose bowel cancer and they’re not 
actually doing very much of it. .. If all Consultant Gastroenterologists suddenly did 
one extra endoscopy list a week … you’d suddenly have 50% extra capacity but of 
course everybody has got a full job plan, we’re pulled in lots of directions….’ – 
National interviewee 
 
Though most lists provided by medical endoscopists are performed by gastroenterologists, 
lower GI and upper GI surgeons will undertake a number of sessions on a weekly or 
fortnightly basis. It was noted that while endoscopy is high up the list of priorities for 
gastroenterologists, this is not necessarily the case for surgeons, as their theatre lists and other 
fixed commitments take precedence. This means that lists may either start late, and therefore 
may not be able to accommodate as many cases as they should or may need to be covered 
at short notice.  
 
It would appear that, in the main, surgical endoscopists do not have the time to take a leading 
role in endoscopy – essentially they become part of the provider service and not part of the 
management service. It was felt by some surgical endoscopists that this could potentially lead 
to their contribution being devalued. Indeed, the view was expressed by some that surgeons 
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might not be necessary as providers of endoscopy procedures at all. This was countered by 
the surgical argument that without their contribution, there was a risk that continuity in the 
care of patients and their diseases might be compromised i.e. there would be one group of 
clinicians diagnosing a disease and another group of clinicians treating it; and that emergency 
care may also be compromised if surgeons do not retain their skills in endoscopic work.  
 
‘…surgeons doing Endoscopy get information about the tumours and the diseases 
that they’re treating that can help them modify and improve the surgery they’re 
delivering… is that advantage big enough to justify having part time Endoscopists?  I 
think it is, but many people think it isn’t.’ – National interviewee 
 
‘I think it would be a very negative impact on colorectal services in the UK if there 
was no endoscopy being done by colorectal surgeons….In the emergency setting, 
the requirement for decompressing a colon in a busy unit like ours is probably every 
day.’ – Colorectal surgeon 
 
Future developments may also be at risk if surgeons do not play an active role in delivering 
endoscopic procedures.  
 
‘If we look at local resection of bowel cancers using Endoscopy combined with 
Laparoscopy where you have a surgeon and an Endoscopist working together, if 
those two practices aren’t joined up then it’s very difficult to engineer that particular 
development and it’s actually quite difficult to envisage it or conceptualise it because 
there is nobody working in both areas...’ – National interviewee  
 
In general, cross cover arrangements for units are often complex to manage and maintain as 
gastroenterologists, Nurse Endoscopists, and upper and lower GI surgeons, while all 
theoretically available to perform endoscopies, are unable in practice to provide like for like 
cover i.e. surgeons will perform upper or lower GI procedures only whereas 
gastroenterologists will do both. Nurse Endoscopists may also perform either upper or lower 
GI procedures only. This has an ongoing impact on covering routine, as well as emergency 
endoscopy lists, and is seen as being particularly challenging for holiday cover arrangements.  
A number of units mentioned trialling ‘buddying’ arrangements for their consultants.  
 
‘Cross cover … could be a little bit of an elephant in the room to start with… some 
surgical team members would have set lists on set days and through no fault of their 
own would have other commitments they would have to cover...  Some people 
have tackled that by saying to the surgical team you have four slots and you use 
them between you and you should always use them.’ – National interviewees  
 
‘… if one endoscopist was off, then this buddy would step in …especially for the 
colorectal team where there’s difficulties if they’ve got on call commitments.  … if 
they have to do a post-take ward round following being on call the previous 
evening, you can have delays in getting to the endoscopy department.’ – Endoscopy 
nurse lead 
 
Other staff groups within the endoscopy team 
The largest professional group among non-medical endoscopists is nursing but there are 
endoscopists who are radiographers, physiotherapists and Operating Department Assistants - 
a background in nursing is therefore not a pre-requisite to becoming a practitioner. It is 
feasible for example that the physicians’ assistant type role could be developed in this way, as 
it is in the US. The view was expressed that it would be possible to train a new cohort of 
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practitioners that possessed technical expertise in a limited range of procedures such as 
endoscopic tests and that this might help to reduce the reliance on the nursing profession to 
expand capacity in endoscopy units. There was a note of caution though about the danger of 
taking staff from one under-resourced area of the workforce, to shore up another.  
 
‘The entry point could be radiographers for instance, or operating department 
practitioners … they are quite technically minded people and yet understand about 
patients as well….On the other hand they’re not specialities that are overflowing with 
people either so we’ll just be robbing Peter to pay Paul if we’re not careful but it 
does provide quite a broad base.’ – National interviewee 
 
Specialist Screening Practitioners work specifically for the Bowel Screening Programme. They 
do not perform procedures themselves but manage their own caseload of patients going 
through the screening process and beyond. It is a requirement of an SSP to be a registered 
nurse and to have undertaken a module at degree level on the role. Though dedicated to the 
Screening Programme, SSPs can be a source of useful support and advice for endoscopy 
nurses, particularly in areas such as advanced communication skills. However, it was reported 
that some units may be considering using an administrative role at a lower pay band to 
undertake the data collection element of the role in order to keep costs down. 
 
‘We acknowledge that we are running quite an expensive model given that we’re 
using two specialist screening practitioners on each bowel scope screening list.  
Other centres are exploring the use of Band 5 nurses and other grades of staff to 
support the lists in terms of data collection, so perhaps a Band 4 or a Band 5.’ – Lead 
specialist screening practitioner 
 
Interviewees noted that unqualified staff or Health Care Assistants (HCAs) also play a vital role 
in many endoscopy units, though their skill mix and duties can vary quite considerably 
between units. This appears to be a relatively flexible workforce, with the ability to adapt to 
suit local circumstances and needs. A number of interviewees talked about upskilling their 
HCAs to undertake additional activities in the face of recruitment difficulties for qualified staff. 
However, vacancy rates for this staff group are also reported in the JAG return as being close 
to the 10% figure. 
 
‘The Band 3s are exceptionally good.  Our Band 3s we’ve got are absolutely first 
class. …you could have one/two Band 3s – we’re also looking at Band 4s as well – 
that will be trained up to a competency level to be able to deal with everything else 
that needs doing, all the technical stuff that needs to be done in the suite.’ – 
Endoscopy nurse 
 
Administrative staff play a key role in the smooth running of a unit too. A number of 
interviewees commented on the investment they had made in senior unit managers or 
administrators and the payback this had generated as the more administrative staff 
understand the procedures the unit undertakes, the more efficiently they can manage the lists 
and rotas. In addition, a knowledgeable administrative function can provide additional support 
to clinical staff and patients alike by providing pathway enhancements such as clerical triage 
and reminder calls.   
 
‘… I think the thing which has made the biggest impact is persuading the trust to 
invest in a dedicated endoscopy manager ...  Because it takes a huge amount of time 
and they need the autonomy, support and equality to be able to make changes..’– 
Gastroenterologist 
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‘I think we’re seeing a lot more efficient booking of patients.  An example would be 
there would be a patient who needs some therapeutic technique done, and they’ve 
been booked onto the wrong list…who it’s booked into, they couldn’t do the 
techniques; that’s a wasted slot…But now the admin staff have an understanding 
who can do what and what the most appropriate list is.’ –Clinical lead 
 
There seems to be a limited literature base on other staff groups within the workforce, such 
as sterile service staff. One studylxxv explored job satisfaction and education opportunities, 
based on a survey of members of the Institute of Decontamination Science.  The study 
concludes that job satisfaction could be increased through greater educational opportunities, 
options for career progression, increased profile of the profession and an increase in pay 
bands.   
 
Our literature search found little in the way of evidence relating to job satisfaction as a whole.  
A qualitative analysislxxvi, involving four focus groups of medical, surgical and nursing 
specialists in England and Wales, captured some disillusionment amongst endoscopy units, in 
their ability to affect change and improvement.  Barriers to service improvement included: 
understaffing, volume of administrative work, lack of long term planning, poor referral 
information, and the perceived place and visibility of the endoscopy unit within the larger 
organisation.  Facilitators included: more Nurse Endoscopists, new guidelines for referral and 
management, the use of “prep” nurses and more specialist staff.   
 
The Independent Sector 
While there may be some spare physical capacity within the independent sector, this is not 
necessarily matched by a cohort of readily available trained staff. Though independent 
organisations do employ their own medical staff, most doctors providing services in the 
independent sector are NHS employees with existing commitments and their ability to do 
more in the independent sector is therefore limited. Nurse recruitment and retention is also 
an issue for the independent sector. Some independent providers are prepared to pay salaries 
in excess of NHS salaries to attract Nurse Endoscopists but this strategy is not guaranteed to 
resolve recruitment challenges.   
 
‘I think the private sector has no spare capacity, because the people doing it are the 
same people who deliver the NHS work. So the only additional capacity they can 
offer is rooms and infrastructure that’s under-used.’ – National interviewee   
 
‘You know, utilisation of units is a main issue …even our units, they're lovely units; … 
but we can’t use them as much as we would like to.  I mean we could have evening 
lists; we could have weekend lists but unfortunately we haven’t got enough staff to 
cover those lists…’– Clinical lead for endoscopy, independent provider 
 
The independent sector is not generally set up to train junior medical staff and this is the case 
for endoscopy service providers. This means that training non-medical endoscopists can be 
problematic though there were examples of this happening in some parts of the country.  
 
‘One of the positives of the independent sector is you’re not slowed down because 
you’re not training junior doctors or registrars and it’s all consultant-led, but the 
downside is you haven’t really got that capacity or ability to maybe train your own 
Nurse Endoscopists.’ – Clinical lead for endoscopy, independent provider 
 
Summary 
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In summary, workforce was clearly the main issue of concern for services struggling to keep 
pace with rising demand. It is clearly a complex issue, with no ‘quick fixes’. It would therefore 
be beneficial for stakeholders from across the health service to work together to implement 
solutions in a strategic way. 
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3.3 Service development and improvement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background 
With the introduction of JAG and GRS, quality in endoscopy services has been put in the 
spotlight. The work of the JAG and its accreditation process is universally recognised by those 
we spoke to and survey respondents as improving quality and productivity and it was noted 
that other countries look to these models to improve their own services.   
 
‘… there’s been a transformational change in Endoscopy over the last 10 – 15 
years…not just in how we perform but our whole attitude to it.  … although… there are 
on-going challenges to improve standards, efficiency and deal with ever rising 
demands, there is … a definite change of mind set within the profession which allows 
us to sort of tackle this.’ – National interviewee 
 
Findings 
There are tools available to endoscopy units to support quality and service improvement, 
notably the PPAT toollxxvii. Developed by the JAG, this toolkit aims to assist endoscopy services 
in assessing demand and capacity; waiting list management; booking and choice; 
performance and productivity; and workforce.  Evaluation has found that units completing the 
tool since June 2012 were more likely to achieve waiting times targets for symptomatic and 
surveillance waitslxxviii. 
 
Following the introduction of the bowel cancer screening programme, there was a 
recognition of the impact on demand and capacity, which led to a number of other national 
initiatives focused on service improvement and productivity to create efficiencieslxxix.  A key 
review was undertaken in 2012 by NHS Improvementlxxx, working with 14 NHS endoscopy 
services in England. A rapid review was undertaken at each of the 14 services, looking at 
clinical and administrative processes, and highlighting six areas in relation to service 
improvement and productivity as follows: 
1. Operational management:  The placing of the endoscopy service within its parent 
organisation and visible ownership of the service can influence performance, through 
competition for resources; collaboration between teams; and unclear governance and 
decision making.  Administrative staff often reported scheduling conflicts where 
decisions are made at the last minute and may impact other teams; in one case, 25% 
of an administrator’s time was spent reworking schedules.   
2. Data collection and planning:  Information is critical to support planning, facilitating a 
greater understanding of patient movements, room turnover and waiting times.  
Recommendations 
• NHS England should support services to achieve and maintain JAG 
accreditation. Services should also be encouraged and enabled through 
the commissioning process to make use of appropriate productivity tools. 
• Commissioners should consider innovative ways to meet rising demand, 
including alternative pathways and processes, such as supporting Straight 
to Test access to endoscopy through telephone triage/pre-assessment 
which would help to speed up diagnosis. In addition, increased 
collaboration between endoscopy units and strengthening links at the 
interface between primary and secondary care could help to improve the 
quality and appropriateness of referrals.  
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3. Demand:  The review highlights variations in how patients on different pathways are 
managed suggesting that some patients may be experiencing more delays as a result 
of how pathways are prioritised.  A nurse-led pre-assessment is part of the bowel 
screening programme pathway and some units are now adopting this for elective 
patients as it has been shown to reduce non-attendance and same day cancellations 
(the site visits reported significant variation in did not attend (DNA) rates, ranging from 3 
– 20%).   
4. Capacity: This includes exploring issues which impact on daily schedules, such as late 
starts, portering delays and the time taken to prepare patients exceeding expectations.  
This involves workforce planning, room scheduling and preparation, availability of 
equipment and resources to support patient preparation.  The NHS IMAS Intensive 
Support Team has developed a tool to support units to manage capacity. 
5. Variation: Understanding variation between teams, individuals and rooms can help to 
identify opportunities for improvement.  Not all variation will be unjustified but there 
may be opportunities to learn from good practice.   
6. Patient experience: This includes providing good quality information, increased 
choice for patients and integrating patient feedback into service management.  
Examples of good practice include the use of a DVD at University Hospitals 
Birmingham NHS Foundation Trust to inform patients of different procedures; and a 
hand held device to collect patient feedback at Gateshead Heath NHS Foundation 
Trust, used to evaluate service changes. 
The Productive Endoscopy Unit Toolkit 
The recent NHS IQ service improvement initiatives resulted in the publication of The 
Productive Endoscopy Unit Toolkitlxxxi which is now readily available to units. The toolkit helps 
units to explore team working, scheduling, referral management, pre-assessment and patient 
preparation, session start up and patient change-over, consumables and equipment, 
handover, recovery and discharge. It also contains many helpful practical examples of the 
actions taken by a wide range of units to improve their efficiency and productivity. One unit 
we spoke to had undertaken a considerable amount of work looking at streamlining their 
pathways and patient flows. It was noted that this kind of work takes time, energy and 
commitment and strong leadership is required to guide teams through and keep motivation 
and momentum going.   
 
‘I think any unit could make gains of about twenty percent in terms of activity if they 
really embrace the whole sort of productivity toolkit... The problem is it’s difficult for 
people to stop and think when you’re in a busy clinical job; they just don’t feel like 
they have the time to dedicate to these things.’ – National interviewee 
 
In other examples of lean thinking from the literature, the pathway for un-sedated patients 
receiving upper GI endoscopy has been reviewedlxxxii.  The process was reduced from 19 to 11 
steps as a result, and the maximum lead time was reduced from 375 to 80 minutes. Changes 
included the removal of the recovery unit for un-sedated patients and a review of the physical 
layout of unit and patients’ journeys through the unit. The process has been piloted and 
tested in another Trust for applicability. In another organisationlxxxiii, which has the shortest 
average pre-procedure time, front desk staff communicate with endoscopy personnel using 
walkie talkies to ensure patients are sent when the room is ready; an assigned “traffic director” 
is responsible for ensuring patient flow is as smooth as possible. 
 
Other examples of seemingly modest changes making big differences from examples shared 
with us by interviewees and survey respondents include the introduction of short daily 
‘huddles’ or meetings to discuss activity for the day ahead and to enhance communication 
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more generally within the unit, and daily vetting of two-week wait referrals.  One unit we 
spoke to had introduced a ‘Manager of the day’ system, whereby the nurse manager in 
charge that day deals with all day-to-day issues and escalates problems as necessary. This 
arrangement made communication more efficient and developed a more distributed style of 
leadership within the department which was seen as valuable in gaining buy-in to service 
improvement activity.  
A survey respondent meanwhile highlighted their unit’s introduction of an in-house ‘stock 
shop’ which enabled them to extract more value for money from their procurement of 
consumables and to stock their rooms more efficiently, ensuring that lists were not delayed 
because items of equipment or other supplies were not readily available.  
 
We’ve almost got like a shop within the department – so the stock is theirs.  …they 
come once a week and scan it and replace anything we’ve used.  …So we've never 
run out of products.  We've never been overstocked by products, and we don’t have 
things going out of date sitting on the shelves.  But equally I think in the first six 
months we probably saved about £8,000. – Lead endoscopy nurse 
 
Potential for further efficiencies 
Many units responding to the qualitative survey report that they believe they can still extract 
efficiencies out of the system by better list management, cross-cover arrangements, 
improving cancellations and Did Not Attend (DNA) rates etc. with 16% assessing themselves as 
being below a mid-way point for operating at maximum efficiency. However, many of the 
interviewees we spoke to also felt that much of the ‘low hanging fruit’ had already been 
addressed in their own units and that any other actions they could reasonably take would be 
either very time consuming or would require additional investment in financially constrained 
times. It does appear from our study that many Trusts have invested quite considerably in 
endoscopy services over the last few years, whether by creating new rooms, new 
decontamination kit or employing more staff. However, survey respondents and interviewees 
alike mentioned developments they would like to see happen but which were unlikely in the 
current financial climate.   
 
One such example was given from a site that had already had approval of its business case to 
reconfigure its endoscopy rooms to make the service more efficient. However, funding for 
the capital work had been delayed in the last financial year and it was looking unlikely it would 
be approved in this financial year due to other Trust priorities. There is also the issue that the 
more activity is undertaken by units, the quicker the turnover of equipment. However, a 
number of survey respondents commented that their Trusts were delaying replacing older kit 
because of financial constraints. As equipment becomes older, it inevitably raises concerns 
about reliability. 
 
‘…some of the equipment…was variable, but certainly you would have questions 
where certain pieces of kit were having to be turned around quite quickly and then if 
one of the decontamination washers went down, it all stacked up and led to delays.’ 
– National interviewee 
 
In addition, any new technological developments which could increase efficiencies may not 
be fully taken advantage of if the capital investment is not forthcoming.  
 
There is some competition for capacity in units with other services and tests taking up lists. 
Developments in these services can also be impacting negatively on demand. For example, 
EBUS is a more sophisticated bronchoscope with an ultrasound probe - it requires two 
operators to perform and it takes longer than an ordinary bronchoscopy (instead of between 
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six to eight minutes, or 20 minutes if complicated, an EBUS takes between 20 minutes and 
three quarters of an hour). Before EBUS was introduced, a surgical procedure was required for 
a lung biopsy on a lymph node, so the activity has now moved from surgery to the 
endoscopy unit if this is where EBUS is usually performed.  
 
If the work was re-provided elsewhere, providing of course, that more general space 
constraints in an acute hospital don’t preclude this from happening, this would free up 
additional capacity for endoscopy work. A number of units responding to the survey and a 
number of interviewees noted that their units were either in the process of negotiating the re-
provision of other activity elsewhere, or had recently done so. There are cost implications 
here though as the infrastructure available within the endoscopy unit has to be replicated 
elsewhere. In one unit, it was reported that the imminent re-provision of cystoscopy out of 
the endoscopy unit would free up six lists. However this re-provision meant an investment of 
£350k in replacement equipment and nursing staff. On this occasion this investment has 
been supported by the Trust’s commissioners in order to reduce waiting times.  
 
Leadership and direction 
A number of interviewees talked about the importance of strong leadership within the 
endoscopy service and the ability of the triumvirate of lead nurse, manager and clinician to 
build a good working relationship together to sustain and develop service improvement. The 
importance of establishing a good relationship with the Trust and its overall management 
more generally was also stressed in order to ensure that endoscopy has a strong profile 
within the organisation and is able to be more autonomous, or more ‘in charge of its own 
destiny’ within the management structure.   
 
‘This is where clinical leadership is so important, somebody just to stand back and 
say well this is completely unacceptable... I always say the holy trinity of an 
endoscopy department is the lead consultant, lead nurse and the service manager. 
And if you can get those three people working together then you’re unstoppable.’ – 
National interviewee  
 
Referral management 
Other areas for units to address to improve productivity and reduce inefficiencies include 
referral management and consistency of surveillance practice. A Cochrane reviewlxxxiv  
investigating interventions to improve outpatient referrals from primary care to secondary 
care, classified interventions into three categories: educating healthcare professionals, 
organisational changes (systems of referral) or financial interventions.  Educational 
interventions were the most promising and those involving secondary care specialists and 
structured referrals sheets when distributing guidelines for referral were shown to impact 
referral rates.  Interventions that included passive dissemination of guidelines with feedback 
about how they are referring were shown to be ineffective in quality improvement. There was 
limited evidence on organisational interventions although the authors concluded that 
providing a second opinion before referring may reduce unnecessary referrals.  The authors 
found that there was not enough evidence to establish the use of financial incentives in 
quality improvement of primary care referrals. 
 
The quality of GP referrals as reported by interviewees and survey respondents is seen as 
variable and could be improved. Some units are managing this proactively by working with 
local GPs to develop their knowledge and skills.  
 
‘Well we've written some referral guidelines which are obviously modelled on the 
General National Guidelines for referrals for routine procedures, and made them 
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really user friendly, … in all units we have GP liaison people and they’ve gone to all 
the surgeries to distribute this.  …  We’re involved in GP training sessions… we do 
regular referral appropriateness, audits, and obviously pickup if there's a surgery that 
maybe we feel doesn’t refer particularly appropriately, we go in and try to educate.’ - 
Clinical lead for endoscopy, independent provider 
 
The view was also expressed however that ‘managing’ the quality of GP referrals should be 
undertaken within general practice as this may be more palatable than intervention by the 
acute sector. The point was made that action is taken when it appears GPs are referring too 
much but those who are not referring enough are not as visible, and yet, this is as much, if not 
more of a quality concern.  
 
‘So it’s all about getting the GPs to refer early; lower their threshold, but that will 
mean that they’ll be a large amount of benign things discovered. ‘– National 
interviewee  
 
Lowering the referral threshold under the revised NICE guidance published in June 2015 is 
not seen as likely by interviewees to improve GP referrals and may mean people on a non-
urgent pathway are more disadvantaged. It may also mean that patients who were previously 
on a non-urgent pathway will now be on an urgent pathway. However, it has also been 
suggested that GPs are largely unaware of the new guidance and may not change their 
practice without some further means of facilitating its implementation. A recommendation 
concerning the dissemination of the new referral guidelines was made in Achieving World-
Class Cancer Outcomes. Furthermore, the new cancer strategy also suggests a streamlining 
of urgent and non-urgent pathways, which would mean all patients should receive test 
results within 4 weeks of referral. 
 
The literature suggests that improving compliance with guidance may help to address the 
issue of appropriateness and that the best approach is via active educational interventions 
rather than passive dissemination of guidance.  Recommendations include the use of clinical 
audits by endoscopy units and GP practices to understand the local context; and 
development of education programmes to improve the quality of referrals (including 
evaluation of the impact by measuring referrals before and after).  It has also been suggested 
that robust referral guidelines with clear guidance on the pathways for high risk patients is 
critical for direct access endoscopylxxxv. 
 
The ability of GPs to consider the most appropriate pathway for patients who might be too 
frail to subsequently undergo procedures was also raised in our research.  
 
‘…where there is capacity to actually potentially reduce demand is to have a more 
thorough assessment of the patient’s total health condition before automatically 
sending them for a colonoscopy. We would be sent some patients by GPs who are 
following the letter of the law and sending us an urgent referral …it would have been 
better for them to have just a straight CT scan and a conversation because we were 
never going to get into a position to be able to operate on them and in fact even 
doing the colonoscopy is quite risky for some of those patients.’ – National 
interviewee 
 
While there is some attention being paid to GP referrals, managing consultant to consultant 
referrals for endoscopic tests is not without challenge. These can account for the largest 
proportion of endoscopic activity in a unit and more could be done to improve the pathways 
internally to ensure that patients are not referred for endoscopic tests without other 
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appropriate diagnostics having been undertaken such as blood tests to measure antibodies 
for coeliac disease.  
 
Direct access  
Direct access for upper GI endoscopy is recommended by NICE guidance and according to 
the literature direct access arrangements have been widely implemented to facilitate timely 
referrals.  A survey by the BSGlxxxvi found 74.8% of its members offered direct access 
endoscopy – however, only 10% were found to offer “true” direct access, i.e. direct referral to 
endoscopy carried out without selection by a hospital consultant.  The audit of 4262 patients 
(covering the period 2004-2011) assessed the appropriateness of direct access referrals for 
upper GI endoscopy, assessing the diagnostic yield of such referrals and the cost of the direct 
access service.  The findings showed 92.2% of upper GI endoscopies in patients aged less 
than 40 were normal and an additional 5.8% could have avoided endoscopy and been 
offered alternative treatment with proton pump inhibitor or H2 antagonist.  Overall, 87.6% of 
patients (3734) had a normal endoscopy, suggesting a significant rate of unnecessary 
procedures – in addition, 52% of respondents offering direct access had waiting lists of over 
six weeks, suggesting the unintended consequence of impacting capacity for other cases.   
 
Achieving World-Class Cancer Outcomes recommends that NHS England should mandate 
that GPs have direct access to key investigative tests, including endoscopy, as it is felt that this 
could save time and outpatient appointments when a GP knows which test to order.  
 
The Productive Endoscopy Toolkit recommends introducing telephone triage/pre-
assessment on a ‘Straight to Test’ pathway. Pre-assessment or triage is usually undertaken by 
a member of the unit’s nursing team who, while providing information to the patient, can also 
gather information about the patient’s social circumstances which might have a direct impact 
on their suitability to undergo the procedure.  
 
‘…pre assessment was about preparing people medically but also preparing them 
emotionally for the procedure that they were going to come in for and attendance 
tends to be improved if you’ve got pre assessment.’ – National interviewee   
 
In order for the process to work efficiently, information provided to the unit by the referring 
GP should be comprehensive and standardised. 
 
Direct access removes the need for an out-patient review before a test which can potentially 
speed up diagnosis and free up clinical time to undertake scoping activities, providing the 
physical space is also available.  
 
‘We thought that the clinic assessment added very little to the patient’s journey and 
why not just scrap that, triage the patient over the phone by a nurse with a set of 
fairly standard questions just to make sure that doing a colonoscopy was safe and a 
good idea and then the patient could go straight to their colonoscopy or flexi-sig. 
…the doctors who are in clinic could do something else and the commissioners pay 
less money cos they’re not paying for the clinic so everyone benefits…. the benefits 
in terms of the patient pathway and saving money on RTT fines was thought to 
outweigh the financial disincentive of losing clinic activity.’ – National interviewee 
 
However, it was suggested by interviewees that in the case of a negative test the need for a 
follow-up appointment in a clinic remains as these patients are experiencing troublesome 
symptoms which require further investigation. Therefore, the need for many patients to be 
seen in an outpatient clinic, is delayed, rather than removed.  
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The introduction of a direct access23 pathway in Leicester, where high risk patients were sent 
straight to test without outpatient assessment, resulted in speeding up the diagnosis of 
colorectal cancer by 15 dayslxxxvii.  A small auditlxxxviii of 2-week straight to test referrals to 
Mayday Hospital (now Croydon Health Services NHS Trust) over the period of one year found 
straight-to-colonoscopy for urgent suspected cancer referrals to be a safe, feasible and cost-
effective method for delivery of the 62-day target with no impact on endoscopy waiting list.  
Another audit of referralslxxxix via the 2-week cancer pathway at Eastbourne District General 
Hospital aimed to compare the information in GP referral letters for straight to test cases with 
the information in surgical assessment letters for cases referred for outpatient assessment.  
The results suggest that GP assessments were less comprehensive, due to the accuracy of 
rectal examination and surgeons’ use of rigid sigmoidoscopy; the conclusions suggest that 
routine use of rigid sigmoidoscopy in general practice could improve straight-to-test referrals.   
 
It should be noted that although published recently, the audits referred to above were based 
on data which is now ten years old and therefore won’t reflect recent service changes. The 
ACE programme (Accelerate, Coordinate and Evaluate), led by NHS England and supported 
by Cancer Research UK and Macmillan Cancer Support, will hopefully produce a robust body 
of up-to-date evidence. The Programme is exploring best practice and innovations in a 
number of sites aimed at enabling earlier diagnosis of cancer, including GP direct access and 
self-referral.  It is expected that the first outputs in the form of ‘How to’ guides will be available 
during autumn 2015, with a full evaluation to be concluded sometime after September 2016.  
 
‘That’s what we would hope to see in evaluation, a) clinically is the straight to test 
pathway better but also economically, you know, what are the implications, does it 
mean you have to increase your capacity for example.  And that’s particularly 
relevant in a direct access where there are a lot of people concerned that should you 
give GPs direct access to both flexi-sig and colonoscopy that that would lead to a 
huge increase in the number of patients referred for those tests.’ – National 
interviewee 
 
Pre-op assessment and reminder calls 
Effective pre-op assessment and telephone reminder calls can help to reduce the number of 
late cancellations or DNAsxc. This is also the experience of those units we spoke to and 
respondents to the qualitative survey.  
 
‘We pre assess every colonoscopy patient so actual DNAs for colonoscopies is 
minute, if they're going to DNA they DNA from their pre assessment so it doesn’t 
reach the capacity for the suites.  The 2 week DNA rates… I think it’s around about 2% 
…a nurse rings them and talks to them and agrees the appointment with them when 
they can.’ – Lead endoscopy nurse 
 
This is reflected in a position statement from Bowel Cancer UKxci which suggests that units 
consider introducing direct booking and pre-assessments to minimise non-attendance. A 
studyxcii comparing face-to-face and telephone pre-assessments for screening 
colonoscopies randomised 6,600 patients to receive either a face to face or telephone 
assessment.  Those who responded to an invitation for a phone consultation were less likely 
                                                        
23
 The standard referral route of GP to outpatient clinic was replaced by a protocol driven sequence 
based on the patient’s declared symptoms, with the initial consultation being replaced by the first test 
taking place within 31 days.  
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to go on to attend colonoscopy than those attending face to face appointments, suggesting 
that phone assessment may not be a viable approach to increase uptake. 
 
Reminder texts are quite common practice in hospital outpatient settings and the IT systems 
are set up to work directly from the PAS (Patient Administration System). However, more than 
one interviewee noted that as their endoscopy activity was coded as inpatient activity on their 
PAS, the automated text messaging does not work and reminder texts have to be made 
manually. There is therefore a trade-off between the time taken and resource used to carry 
this out and the benefit to be gained from reducing DNAs and cancellations.   
 
There is some difference in opinion as to the most appropriate time to make reminder calls – 
too far in advance and the reminder effect is diluted, too close to the day of the procedure 
and a resultant cancellation by the patient means it is unlikely their slot can be reallocated. 
Three days before the procedure was considered by a number of units we spoke to, to be the 
optimum length of time to make the call.   
 
 
 
Patient choice 
On a related note, there is interest in offering more patient choice with regards to 
appointment scheduling but our search suggests a lack of literature reporting innovations in 
this area.  We found reference to a hospital service in Norway which has experimented with 
drop-in access for gastroscopy.  The evaluationxciii compared the patient and staff experience 
of drop-in versus appointment-based access.  The mean time from initial GP consultation to 
gastroscopy was 3.6 weeks for the drop in group and 14 weeks in the appointment group.  
The service experienced a 47% increase in the number of procedures performed and the 
proportion of examinations with pathological findings increased from 42% to 58%.  The GPs 
and patients reported higher satisfaction with drop-in access; hospital staff also reported 
general satisfaction but found their working days were more unpredictable. 
 
Surveillance protocols 
Surveillance protocols for patients will vary between units but a closer focus on whether 
these patients require further investigations and if so, the most appropriate timing of these, 
can reap rewards. The literature reports on one unit that managed to remove 37% of patients 
from its list without them undergoing a colonoscopy and reduced DNA rates from 7.6% to 
less than 1% by introducing a nurse-led surveillance management programmexciv.  
 
Our research suggests that a number of units are undertaking a more systematic approach to 
scrutinising their surveillance lists, in order to manage their demand. 
 
 ‘… we’re really re-evaluating and revalidating all these surveillance patients going 
through – putting the Nurse Endoscopist to one side an afternoon a week, so taking 
them out of endoscopy, giving them an additional role … validating all these referrals.  
We do take some off the list…’ – Endoscopy clinical lead 
 
Opportunity costs are at play here however as it takes time to revalidate surveillance patients, 
and this is time that cannot therefore be used for scoping. Units are juggling between setting 
aside time for surveillance revalidation to reduce demand and using that time to scope to 
provide capacity.  
 
‘We try and get one admin session a week to do our admin, and then a validation 
session as well.  But the trouble is when you're short-staffed you end up then having 
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to help out, or a doctor’s off sick so you end up scoping, you know.’ – Nurse 
Endoscopist 
 
Research in endoscopy services 
There is a suggestion in one studyxcv that involvement in research may have a positive benefit 
on the quality of endoscopy services.  The Northern Region Endoscopy Group (NREG) was 
founded in 2007, encompasses 17 endoscopy units and has become a respected and 
successful collaborative research network. The network contributes to trials, holding grants 
worth over £1.5 million.  The collaborative model is thought to be a critical factor in advancing 
improvement and innovation. Though no questions were asked specifically about the ability 
of endoscopy units to be involved in research activities, a number of interviewees 
commented on this aspect of the service, suggesting that service pressures were restricting 
their ability to be as involved in research as they would like. This echoes the findings of an 
earlier study by Cancer Research UKxcvi on the ability of the NHS to maintain research capacity 
and competency in the face of rising service pressures  
One unit also indicated that their energies were focused on audit activity in order in part to 
satisfy JAG requirements, rather than on other types of research. 
 
Summary 
In summary, a huge programme of improvement work has been undertaken in endoscopy 
since JAG was set up in 1994, and it is widely agreed that this has resulted in an internationally 
renowned high-quality service. However, as demand rises, services will need support to 
maintain these gains and continue to make improvements. 
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3.4 Data Quality and Access 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background 
Good quality data is vital if we are to understand current and future levels of endoscopy, and 
the reason for the endoscopy taking place. It also helps services to understand how they are 
performing in relation to one another, and internationally, and enables improvements to be 
implemented and measured. Improving data quality and access will therefore help to support 
efforts to cope with rising demand and evaluate these.  
 
 
Findings 
Measuring Outcomes  
The challenge ahead is to measure the true outcomes of endoscopy services, for example, 
reduced mortality from colorectal cancer.  Bowel Cancer UK suggests that completion rates 
should be a key indicator of qualityxcvii; incomplete tests can lead to repeat procedures which 
can be distressing for patients and are also more costly for the service, contributing to further 
demand.  It also suggest rates of post-colonoscopy colorectal cancer should be monitored, 
to track miss rates and to learn why polyps have been missed or not fully removed, to 
improve diagnosis and survival rates.  This kind of measurement is already being captured in 
some areas and shows significant variation between hospitals and individual endoscopists in 
the proportion of people they have scoped in the previous five years who subsequently 
develop cancer of the bowel.  
 
‘One of the things that we've done in our colorectal sites group is look at the 
proportion of people with cancer of the bowel who've had a colonoscopy the 
previous five years and you will find that that varies enormously by both hospital and 
individual endoscopist.’- National interviewee 
 
It would be possible to introduce endsocopist-level outcomes in the same way that surgeon-
level outcomes are now routinely published and there was some interest for this.  
 
‘When you have a list of, you know, eight endoscopists, A to G and you know that 
you’re A, and your completion rate is down at 70% and somebody else’s is 95% it 
does focus the mind.’ – National interviewee 
 
However, the methodological issues would be the same for surgical procedures i.e. is each 
endoscopist performing enough procedures for their outcomes to be considered statistically 
significant? Unit-level outcomes may therefore be preferable.  
 
Recommendations 
• The Health and Social Care Information Centre (HSCIC) should work with 
endoscopy providers to ensure that Hospital Episode Statistics (HES) 
contains a complete and accurate record of all NHS commissioned 
endoscopies, making changes to data specifications to identify whether a 
procedure is for surveillance, screening or symptomatic purposes 
• Data on the activity and outcomes of the Bowel Cancer Screening 
Programme should be routinely published in a format consistent with the 
breast and cervical screening programmes. Public Health England should 
also work to ensure there is timely access for researchers to appropriate 
data about the Bowel Cancer Screening Programme  
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‘If we look at complications from say colonoscopy or missed cancer, then that I 
think has to be reported at a sufficient sample size and I think the sample size would 
be at a trust level.’ – National interviewee 
 
The quality and consistency of data produced on endoscopy services more generally was 
raised as a concern by a number of interviewees with disparities noted between the HES and 
DD01 datasets, with HES in particular not containing some important aspects of information 
such as the reason for the diagnostic procedure and the referral route of the patient.  
 
‘If you want to get the number of endoscopies, it’s very difficult data to get hold of, 
you have it recorded inconsistently … you don’t get …how many endoscopies were 
screening, how many were GP referral, how many are routine surveillance … and you 
need that, because each of those are going to grow at different rates …  So that data, 
as far as I’m aware, isn't really coming out of anywhere centrally in a consistent 
manner at the moment.’ – National interviewee 
 
Bowel Cancer Screening Programme Data 
The data published on the activity and outcomes of the National Bowel Cancer Screening 
Programme is not as comprehensive as the data routinely published for other Cancer 
Screening Programmes (i.e. Breast and Cervical)24. Furthermore, the research team was 
unable to access data relating to the Bowel Cancer Screening Programme from Public Health 
England in time to include it in the modelling work for the initial deadline of this project. It is 
felt that the process of assessing and processing information requests for researchers which 
would not disclose patient identifiable information could be streamlined.  
 
The IT infrastructure required for effective data management, and the resources and skills in 
data analysis and modelling were also considered to be in short supply. There is also no 
nationally agreed dataset for endoscopy procedures - it is understood that the BSG 
developed a dataset but that this has not been adopted by the NHS or NCIN. Data on 
endoscopic procedures carried out in primary care is also particularly difficult to obtain.  
 
‘… there’s not a nationally agreed dataset for endoscopy procedures. …you’ve got to 
devise a dataset which is completely aligned to the NHS data dictionary, it uses the 
proper codes and that the burden of collecting the data for the NHS is not 
overwhelming.  So it’s got to be a really carefully thought through dataset.’ – 
National interviewee 
 
This lack of consistency and limited resource might potentially hamper a more strategic 
approach to service development and configuration of services.  
 
Summary 
In summary, there are a number of improvements that can be made to ensure the data that is 
collected is fit for purpose, routinely published and available to researchers in a timely manner 
where appropriate. This will help us to measure the performance of endoscopy services, and 
evaluate efforts to improve the service. 
 
 
  
                                                        
24
 The research team are aware that the BCSP are working on publishing KC73 returns by December 
2015 and KC72 returns by 2016 and are working towards a final version of these for 2020. 
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3.5 New Technologies 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background 
As with any other area of medicine, endoscopy services must continually adapt to new 
technologies and innovations, whether in the development of more sophisticated scoping 
tools, or imaging kit, or new diagnostic tests. Services are currently working to roll out the 
Bowel Scope test into the Bowel Cancer Screening Programme, and the National Screening 
Committee has made the interim recommendation that the Faecal Immunochemical Test 
(FIT) replaces the Faecal Occult Blood Test (FOBT) as the primary test of the Screening 
Programme. Both tests have significant potential to drive demand for endoscopy over the 
coming years.  
 
Findings 
‘Endoscopy is technology driven and we’re currently using a very antiquated tool 
which was developed in the 70s … it is inconceivable that in five years’ time we’ll be 
using the same equipment … Endoscopy is going to change radically over the next 
decade.’ – National interviewee 
 
‘The biggest change that I see coming…is moving more and more towards optical 
diagnosis rather than relying on taking samples.  …we have HD monitors; we have all 
this sort of devices that allow us to really see so clearly.  For example, if we find a 
polyp, you know what sort of polyp it is, …and that may save all of us a lot of money 
… in the main teaching hospitals they’ve started not actually taking polyps out if 
they're sure that they are totally benign …we can see so much better now.’- Clinical 
lead for endoscopy, independent provider 
 
Changes in the equipment being used was seen as likely to happen in the medium term, 
while other potentially more game changing diagnostic tests, would be rather longer in their 
development.   
 
‘I think in the longer term, there will be other techniques …  genomics, the impact of 
DNA testing of stool, competing technologies such as radiology – but certainly in 
the next five to ten years, I don’t see endoscopy going anywhere quick.’ – National 
interviewee 
 
Diagnostic tests 
More recent developments include the introduction of faecal calprotectin tests to help 
distinguish between inflammatory bowel diseases, such as Crohn’s disease and non-
inflammatory diseases, such as irritable bowel syndrome. The use of faecal calprotectin 
should prevent people having to undergo invasive investigations such as endoscopies to 
Recommendation 
• Public Health England (PHE), NHS England and the National Screening 
Committee (NSC) should undertake a strategic planning process to 
ascertain how best to manage the pressures which will inevitably be 
created in endoscopy services by the recommended introduction of FIT 
into the Bowel Cancer Screening Programme. Similarly, the ongoing 
rollout of Bowel Scope into the Screening Programme should take into 
account the pressures services are currently facing. Services should be 
supported to roll out these tests as swiftly as possible. 
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diagnose their condition. The test is recommended by NICE with guidance issued in October 
2013xcviii.  
The FIT25 test will also be a potentially significant development, as it is considered a more 
sensitive test and therefore a more effective test than the current FOBTxcix c. It is also easier to 
use and requires only one sample of faeces, as opposed to the six required for the existing 
FOBT programme. It is therefore hoped it will increase uptake. Introduction of FIT has been 
recommended by the National Screening Committee and is currently subject to consultation. 
Scotland has already announced it will be introduced, and this is likely to be phased in over 
the next two years.  
 
The introduction of breath and blood tests as new methods of screening could ultimately see 
the demand for endoscopic tests reduce over timeci. However, these tests are still in 
development and their introduction into screening programmes in the NHS is likely to take 
many years. Further studies will be required to confirm test reliability and to ascertain what 
additional benefits may be gained over standard methods and the evidence on any new 
screening test will be reviewed by the National Screening Committee before it can be 
adopted. Interviewees were aware of new developments and were cautiously optimistic 
about their potential. However, some interviewees noted that only an endoscopy gives direct 
visualisation of the patient’s insides and this can exclude a large number of diagnoses that a 
breath or blood test can’t do.  
 
‘If a patient comes in and says ‘have I got cancer?’ then one would imagine we could 
design a non-invasive biomarker to help risk stratify that population…But the reality is 
patients don’t come in with that.  Patients come in and go ‘I don’t feel well’.  So you 
have to answer a different question.  Endoscopy gives you direct visualisation and 
allows you to exclude a large number of diagnoses that a breath test or a blood test 
(won’t) …that will be a slow train coming, that's not around the corner.’ – National 
interviewee 
 
CT colonography 
Interviewees and survey respondents alike referred to the benefits of introducing CT 
colonography, (or virtual colonoscopy) which involves using a CT scanner to produce images 
of the colon which are then manipulated and interpreted by a radiologist. This is a less 
invasive procedure than a conventional colonoscopy and sedation is not usually required – 
the procedure is therefore used for people who are too frail to have a colonoscopy, or if there 
are other reasons why a colonoscopy would not be suitable. It is more effective than a 
barium enema testcii and there is continued pressure nationally to phase the latter out. The 
procedure can be performed on standard CT scanners, but units introducing the procedure 
need the right software and radiologists require training to be able to interpret the results.  
 
There were some differences of opinion expressed about comparisons between CT 
colonography and colonosopy though the two tests have similar sensitivity for detecting 
bowel cancerciii. Unlike colonoscopy, tissue samples cannot be taken at CTC and patients 
may therefore require a follow-up test to confirm a suspected cancer. One interviewee 
commented that the technique ‘will never be as good at seeing the bowel as endoscopy’, 
while another suggested the technology would help to detect other cancers.   
 
                                                        
25
 FIT (also known as immunochemical faecal occult blood test, iFOBT, as opposed to the guaiac 
faecal occult blood test.) These tests were introduced in 2001 and detect the globin in faeces rather 
than the haem. 
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‘That’s the advantage of CTC you can get a more definitive diagnosis when it’s not 
just rectal bleeding or change in bowel habit, because you’ll pick up the non-bowel 
cancers.’ – National interviewee 
 
The ability of CT colonographies to detect findings of varying significance can result in 
patients being referred for unnecessary follow-up tests also. According to one studyciv, 30% of 
patients who had a CTC had a follow-up test compared with only eight per cent who had 
colonoscopy - almost a third of follow-up tests for the CTC patients were to investigate small 
polyps that could have been left alone because they were unlikely to develop into cancers. 
 
Other developments 
A systematic reviewcv of the effectiveness of water infused colonoscopy (as opposed to air or 
CO2) was published in 2013. This may become a popular technique in the UK as it is reported 
patient discomfort is less without operation time and intubation rates being adversely 
affected. There will also undoubtedly be significant changes in the sophistication of the 
endoscopy instruments used over the course of the next few years and interviewees felt this 
was likely to see a growth in therapeutic endoscopy and hybrid endoscopic/ laparoscopic 
procedures.  
 
For example, Natural Orifice Translumenal Endoscopic Surgery® (NOTES®)26 is a new type of 
hybrid endoscopic/surgical procedure currently being studied. This approach involves 
intentional perforation of the gastrointestinal tract, allowing access to the peritoneal cavity.  As 
an example, the gallbladder might be removed through the mouth, after a small incision is 
made in the stomach wall via the oesophagus to gain access to the abdominal peritoneal 
cavity. It is suggested that the NOTES® technique reduces post-operative pain, shortens 
recovery times, and improves cosmesis (lack of surgical incision scars).  The first multicentre 
human clinical trial is currently underway in the US27. 
 
Summary 
In summary, it is clear that the service needs to be ready to introduce evidence-based new 
tests as and when they come along. This often requires finding the right balance of 
encouraging, supporting and adequately funding services to adopt new technologies, and 
swiftly taking action to rectify the situation if they are not adhering to best practice. 
 
 
  
                                                        
26
 The NOTES® initiative is a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) 
and the Society for American Gastrointestinal and Endoscopic Surgeons (SAGES). Together, these 
societies have formed the Natural Orifice Surgery Consortium for Assessment and Research® 
(NOSCAR®), a group that provides guidance and oversight and evaluation NOTES® of techniques and 
the related research required. 
27
 www.noscar.org  
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4. Appreciative Inquiry Case study - ‘stepping stones 
to change’ 
 
Background 
An Appreciative Inquiry event seeks to support and enhance good practice, while drawing out 
transferable lessons about what works and how. It also provides a positive framework to think 
forward towards further improving an organisation or projectcvi cvii.  The method involves 
asking a series of positively framed questions to encourage the teams involved to put energy 
into finding out what went well, and why, rather than spending too much time focusing on 
(and therefore reinforcing) problems or failures. 
 
Royal Liverpool University Hospital – Endoscopy Unit  
The endoscopy unit at Royal Liverpool University Hospital has made substantial progress over 
the last five years in the way that it works and now operates in a way that engages and values 
all parts of the team.  In terms of activity, they are the second largest unit in the country to 
operate from one site and have managed to keep pace with increases in activity by thinking 
about and improving every aspect of the delivery of their service.  
 
People  
In 2009, the unit faced a watershed moment when its JAG accreditation was delayed due to 
a requirement for substantial improvements in its workforce domain, particularly nurse 
management. Though a challenging time, the endoscopy lead and consultant endoscopist, 
and the directorate manager (both appointed earlier in 2009) began to change the whole 
nursing management structure; the previous unit manager, nurse trainer and two junior sisters 
and an admin manager retired and were replaced with a higher banded unit manager, a 
deputy manager /nurse trainer and four junior sisters and a new admin manager. Over a three 
year period the unit has therefore managed to develop a new cadre of nurse leaders and a 
well-trained and committed administrative team.  
 
A key feature of the leadership team’s approach has been consistent and meaningful 
engagement with all front line staff – whether nursing, healthcare assistants, administrative or 
decontamination staff and this has been recognised internally with a Trust award for staff 
engagement.  This approach has resulted in incremental rather than revolutionary change – 
as the unit manager explained, there have been many “stepping stones” to get where they are 
now. 
 
Initially, the leadership team worked to develop a better understanding among staff of how 
their role contributed to the whole patient pathway - individual members of staff were given 
responsibility for managing specific projects addressing particular elements of the pathway.  
The unit manager used her newness to the service area to her advantage by questioning and 
challenging staff to explore their roles and relationships with each other and to dispel some 
‘myths and assumptions’ that had built up about what could and couldn’t be done.   
 
The close, respectful working relationship between nursing, medical, administrative and 
management staff is continually nurtured through both formal and informal communication 
processes.  For instance, staff have a weekly ‘activity meeting’ where all staff can discuss their 
progress and concerns, and plan ahead. They decide jointly on a unit ‘rating’ (green, amber 
and red) and whether they need to escalate any specific concerns, or requests such as 
resources for overtime payments to the directorate manager.  It was through this open 
communication that administrative staff were able to express their concerns that as the first 
point of contact for patients, they were often asked clinical questions they felt they couldn’t 
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answer. In response, the team developed clearer guidance to ensure clinical questions were 
passed onto the relevant person. 
 
Supplementing formal meetings, the clinical, managerial and administrative lead speak 
“almost hourly” to ensure that they are up to date with what is happening in the unit. The 
team also has a five minute briefing every morning which everyone attends and where 
information on who is doing what and key messages for the day is exchanged.  There is also a 
nurse manager of the day arrangement whereby a dedicated person deals with all the day-to-
day issues, liaises between people and escalates problems as necessary. In addition, staff now 
regularly attend social events together. This balance of formal and informal allows for a 
flexible approach to managing the unit built around trusting relationships between team 
members.   
 
Outside of the Trust, the senior team has built strong relationships with other providers and 
primary care. The unit has adopted a multi-Trust delivery model for its Bowel Screening 
Programme which was felt to be the most resilient option but which has required a high level 
of trust and transparency to be developed. The relationship with primary care has 
strengthened since the introduction of Clinical Commissioning Groups and GPs are reported 
to be well engaged with the screening programme. 
 
Place 
The Endoscopy Unit and the Bowel Screening Centre are located very close to one another 
on the ground floor of the hospital and both are run by the same clinical lead and directorate 
manager which has led to an integrated approach with increased understanding, flexibility 
and co-operation between the two services.  One of the biggest challenges for the unit has 
been the small footprint they have had to work with.  Very little has changed in terms of 
physical space since the 1990s, though an additional room (which has led to the 
displacement of the staff room off the unit) has just become operational. It is a temporary 
solution until the new hospital, on an adjacent site, is ready in approximately 18 months’ time. 
This will provide the team with a much larger footprint to work within. 
 
While the lack of space has clearly sometimes been challenging, the team has fought hard to 
make it workable.  The Productive Endoscopy project enabled them to work through some of 
the capacity constraints and led them to clearing up and redistributing some of the 
consumables and equipment to create a better patient flow. These are now stored as close as 
possible to the rooms in which they are needed. This has had the effect of improving staff 
relationships on the unit, as people are not fighting for space and the environment is said to 
feel ‘lighter’ and calmer.  
 
The staff are aware that the current space constraints may affect the patient journey and their 
experience. The waiting room can be busy which can potentially affect privacy at the 
reception desk.  In addition, the interview rooms and preparation room (for enemas) are just 
off the hallway from the waiting room.  Consequently substantial physical changes to the unit 
(e.g. creating separate male and female recovery areas, more separating doors, and new 
reception glass frontage), and changes in patient flows have been introduced. Staff awareness 
also enables privacy and dignity to be maintained within these constraints, as far as possible. 
 
One advantage of the close working conditions however has been the opportunities for 
informal communication and the endoscopy lead noted that the team will have to work hard 
not to lose that sense of close working relationships at the new site.  
 
Patients 
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The staff are cognisant of the fact that “every patient that comes through the door thinks that 
they might have cancer”.  The need to be supportive and to try to “make the pathway as 
pleasant as possible” was noted.  Consideration for patients is evident in the waiting room 
where there are signs up to ask those waiting to be mindful of people who are fasting by not 
eating or drinking in the unit.  
 
One difficulty the team encounter is that relatives and friends are not allowed in the unit itself 
– this is a JAG requirement in order to maintain privacy and dignity but it is also a practical 
consideration of space.  Some nurses acknowledged that they struggle with this because they 
feel that patients sometimes need that kind of support and that the wider Trust is very 
supportive of including relatives and carers in all aspects of the care of patients.   
Regular and sensitive communication with patients underpins the team’s approach to 
working .This is evident from the first contact, with the admin team taking their role as 
providing reassurance seriously, through to sending reminder texts for appointments; always 
informing patients if there will be a delay; through to collecting feedback from patients after 
discharge and displaying ‘You said, We did’ posters to let people know how their feedback has 
made a difference. 
 
The team are proud of the excellent patient feedback they receive and their low numbers of 
complaints despite the challenges of the physical environment and undertaking around 
17,500 procedures a year.  
 
There is less opportunity for long-term patient involvement in the running of the unit, 
because most patients come just once, rather than returning regularly over time.  However, 
where possible the team engages patients in designing the service. One example of this is the 
identification of people with autism and learning disabilities in advance and arranging for 
them to have pre-visits to meet the staff and to go into the room where their procedure will 
be undertaken. During feedback and consultation, it was identified that feeling prepared could 
really help to alleviate their anxiety about the procedure for this group of people. 
 
The Future 
The unit has a growing profile within the Trust, because of its development as a strong, 
cohesive team and its income generating ability. This has meant that the Trust has been 
prepared to invest in the service. The team are continuing to look for ways to increase 
productivity and working differently to improve quality and promote efficiency - for instance, 
introducing a managed service contract for all its kit and consumables which it thinks will be 
able to save potentially 14% of its budget.   
 
A key strength of the unit’s strategy is to plan well in advance for staffing needs - it managed 
to get eight endoscopists accredited in April 2014 in order to meet the demands of the roll 
out of the Bowel Scope Screening Programme which started in March 2015.  However, 
recruitment remains a challenge across the region and country.  The changing working hours 
– currently to an 8am-8pm working day but eventually to 7 day working - requires the 
recruitment of more admin and nursing staff to work flexible shifts. The unit is also developing 
a more robust plan for holiday cover and is looking for a way to buddy up consultants to 
provide cross-cover.   
 
The team is striving to improve the quality of everything it does – this is demonstrated by the 
training programme for nursing staff which is delivered by the nurse managers in house. This 
programme will ensure every nurse is brought up to the same level of knowledge and skills.   
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Other developments planned for the next 12 months include developing a nasal-endoscopy 
service, piloting a new electronic consent process using handheld PDAs, and developing the 
organisation’s website to include video resources for patients.   
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5. Discussion and Conclusions 
 
Endoscopy teams that we talked to, and met, and that responded to our survey, demonstrate 
an enormous amount of enthusiasm and passion to improve their service and strive for 
excellence in the service they provide patients. However, the over-riding impression from this 
research project is that units are operating on the margins of optimum capacity in terms of 
staffing.  While they appear on the whole to have been making improvements in efficiency 
and managing their waiting times, this has been at some cost, not just in financial terms 
through the running of waiting list initiatives, but in terms of staff goodwill, as staff are asked to 
provide additional lists over and above their normal working hours.  
 
This ‘just about coping’ situation means there is little give in the system to accommodate 
increased demand and little resilience to respond in the event of any adverse event that might 
affect the availability of key staff.  It also leads to vicious circles developing such as the delay in 
training in order to accommodate full lists to manage demand, which inevitably means those 
staff who are fully trained and competent continue to bear the burden of scoping - this is a 
particularly insidious situation, as the more pressure endoscopists are placed under to provide 
more scoping lists, the more likely it is that they will become less productive and effective, 
suffer from stress or physical problems, or choose to leave.   
 
Our modelling work shows that demand will increase significantly over the course of the next 
five years. Working with Trust chief executives, Local Education and Training Boards (LETBs) 
and HEE, Units must start immediately to plan for the increase in their workforce that this will 
inevitably require. It is a complicated jigsaw and whatever actions are taken to staff endoscopy 
units appropriately are likely to have consequences on other areas of service delivery.  For 
example, a renegotiation of medical rotas to free up the time of Consultant 
Gastroenterologists will mean that another cohort of medics would be required to pick up 
these duties.  Broadening the base for recruitment of non-medical endoscopists is sensible 
but should not place other service areas at risk of having their own staff that might be in short 
supply ‘poached’ by endoscopy services. There is a time lag of approximately two years 
before non-medical endoscopists are fully trained and competent and this means that 
existing trained staff will have to continue to be the backbone of the service. 
 
Unless staffing issues are tackled head on, waiting lists will lengthen and all the sterling work 
undertaken in the last 20 years or so to develop endoscopy services in order to improve 
quality, productivity and patient experience might be jeopardised. There is a very real danger 
that all the progress made thus far in diagnosing and treating all patients, but most specifically 
cancer patients, will be in danger of stagnating at best, or sliding backwards in a worst case 
scenario. 
 
Though the largest proportion of expected increases in activity will come from the bowel 
cancer screening programme, which is funded through Public Health England, there is still a 
chunk of additional activity not related to screening that Clinical Commissioning Groups will 
be obliged to pay for. Though it is assumed that much of this activity could prevent higher 
costs of treatment later on if cancers and other conditions are caught soon enough, it is not 
possible to demonstrate a clear return on investment in the normal short-term budgeting 
cycles of commissioners, which is problematic in terms of engaging commissioners.    
 
A national response is required to address some of the concerns here such as a strategic 
planning exercise for workforce requirements across the broad range of potential non-
medical endoscopists and appropriate training plans and programmes are developed. The 
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development of a national data set for endoscopy services is also a priority. The introduction 
of new screening initiatives, or enhancements to existing programmes should be considered 
carefully in light of these findings to ensure the right balance of ensuring patients who need 
an endoscopic procedure receive one in a timely way, without overloading the service.  
 
At the local level, commissioners must be made more aware of the pressure facing 
endoscopy services and the implications increased activity will have on their budgets. 
Commissioners can do much to support units by providing leadership and guidance on best 
practice in referral arrangements and by supporting developments to improve and streamline 
pathways. Any opportunities to configure services in a more effective way should be explored, 
as should the full potential of local independent providers to deliver a planned, 
complementary service to NHS provision, which does not destabilise the NHS provision by 
cherry picking.  
 
NHS endoscopy services are seen as world-leading with respect to quality and efficiency and 
staff should feel justly proud of their achievements thus far, delivering ever-increasing activity 
with higher levels of clinical quality and patient satisfaction. The service is at a crossroads 
however, and the decisions made in the next few months will set the course for the service 
for many years to come. It seems sensible that these decisions are overseen by a single co-
ordinating body.  
 
We strongly urge the Government and the NHS to work together to act on the 
recommendations in this report to ensure that cancer patients – and indeed all patients using 
endoscopy services – receive timely, high quality care. 
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Appendix 1. Research Aims and Methodology    
 
Research Aims 
 
The aim of this project was to ascertain the barriers to meeting rising demand for endoscopy 
services and how these can be overcome. The work took a mixed-methods approach, 
comprising five elements summarised below:  
 
• A review of literature and evidence, the principal aim of which was to identify key 
themes and issues for further exploration 
The literature base relating to demand and capacity within endoscopy services is significant 
and typically focused more on clinical aspects than on service management.  Recognising 
the full range of activity in endoscopy units and broader influences on demand and capacity, 
our search included diagnostic tests other than endoscopies. For the sake of timeliness, the 
review has taken a pragmatic approach, and whilst we have taken a systematic approach to 
find literature, this is not a systematic review and is not based on an exhaustive search.  As 
with any review, there are some limitations. 
• Qualitative interviews with stakeholders to explore views and experiences at a local 
and national level 
 
Between February and May 2015, 40 semi-structured interviews were carried out with a range 
of participants including gastroenterologists, surgeons, non-medical endoscopists, 
endoscopy nurses, senior managers and policymakers (see Appendix 2 for topic guide). These 
interviews were recorded and the tapes transcribed verbatim. In addition, an Appreciative 
Enquiry event was held with a site that was deemed to be a high performer in terms of 
managing its demand.  
 
• An online survey with mainly free text responses to gather a broader range of 
qualitative responses on the challenges facing endoscopy units and examples of good 
practice 
 
The survey was constructed using Bristol Online Surveys and was distributed to all UK NHS 
and independent sector units through the JAG, at the same time as the JAG April GRS census 
return was issued to sites. The number of responses (n=98) indicates a 21% response rate 
across all sectors.   
 
• Additional questions embedded into the JAG April GRS Census return from 
endoscopy units to capture mainly quantitative data on activity and capacity, with 
some scope for providing additional free text comments 
 
A total of 380 units across all sectors responded completely to the additional questions which 
equates to a 79% response rate. A total of 412 units provided at least a partial response to the 
additional questions. The number of returns received from NHS acute units only (n=207) 
indicates a 94% response rate for this sector, and it is these responses which are the focus of 
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the subsequent analysis. Elements of the analysis are drawn upon throughout the report but a 
full slide set of the results is available through the JAG website28  
 
• An activity and demand model, with a five-year projection of demand  
 
A model has been developed, which builds on baseline activity information to estimate future 
levels of demand for diagnostic endoscopies. The model provides activity estimates to 
2019/20.   
 
This report summarises the main themes and findings from the study, with a series of 
recommendations for endoscopy services based on examples of good practice where found.    
 
Literature and evidence review 
Database searches were undertaken by an Information Specialist at Health Centre Services 
Management Library, University of Birmingham, using the following databases: 
• Medline 
• Embase 
• HMIC 
• CINAHL 
• Cochrane Library 
Our search strategy was based on a combination of controlled vocabulary and free text 
terms, selected to retrieve a manageable number of references. A total of 1062 references 
were retrieved from the search.   
A search of the “grey literature” was also conducted, via the web sites of the following 
organisations:  
Table 4 – Web sites used for literature search 
Type of organisation Organisations/sources included in search 
UK Royal Colleges and 
professional bodies  
RCP London; RCS England; RCN; JAG; BSG 
International bodies and 
groups 
European Society of Gastrointestinal Endoscopy; 
American Society for Gastrointestinal Endoscopy; 
Society of American Gastrointestinal and Endoscopic 
Surgeons; European Society of Coloproctologists; World 
Gastroenterology Association; European Association of 
Gastroenterology and Endoscopy Nurses and 
Associates; Association of Coloproctology of GB and 
Ireland 
                                                        
28
http://www.thejag.org.uk/downloads/National%20Policies%20and%20Reports/GRS%20census%20un
it%20information%20summary_April%202015.pdf 
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Cancer charities Cancer Research UK, Bowel Cancer UK 
National NHS NHS England, NICE, Health Education England; NHS 
Networks 
Public Health England National Cancer Screening Programmes; Atlas of 
Variation - Diagnostics 
Improvement bodies  NHS Institute of Innovation and Improvement; NHS 
Improving Quality 
Think tanks Kings Fund; Nuffield Trust; Health Foundation; Centre 
for Workforce Intelligence 
Trade press  HSJ 
96 references from the database and grey literature searches were selected for the review, 
according to the inclusion and exclusion criteria: 
Inclusion criteria 
• Policy and service perspectives 
• Good practice in terms of operating an endoscopy unit 
• Adult services only 
Exclusion criteria 
• Technical/clinical material i.e. endoscopy techniques, clinical developments, 
effectiveness of diagnostic tests (sensitivity, specificity, positive predictive value) 
unless impacts on activity/demand/capacity 
Qualitative interviews with stakeholders 
 
The views and experiences of those delivering or commissioning endoscopy services were 
explored through interviews with experts at a national level and with clinicians and managers 
in endoscopy units. Interviewees at the national level were identified in conjunction with 
Cancer Research UK. It was originally intended that the selection of these sites would be 
determined by the extent to which they were involved in the Bowel Scope Screening 
Programme, so that there would be representation of a unit from the pilot phase, and first and 
second stage roll-out. Units would then be sampled from these stages based on maximum 
variation to take into account the following characteristics as far as possible:  
• Socio-economic characteristics: e.g. areas with more and less affluent populations  
• Demographic characteristics: e.g. inclusion of areas with more and less homogeneous 
and heterogeneous populations   
• Environmental characteristics: e.g. areas with differing urban: rural population ratios  
• Geographical characteristics: e.g. the sites combined would cover different areas of 
England 
 
Regrettably, it was not possible to select a site from the first stage of the roll-out. A number of 
sites in this category were approached but declined to take part due to service pressures.   
Therefore two of the sites included are from the pilot phase of the bowel scope roll-out and 
one is from the second stage of the roll-out.  
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A total of 40 people took part in telephone interviews between February and May 2015 - 19 at 
a national level and 21 from endoscopy units. Interviewees from endoscopy units were 
selected according to their job role (purposively sampled) and include clinical, managerial and 
nurse leads for NHS and Independent endoscopy services, Nurse Endoscopists, endoscopy 
nurses, Consultant Gastroenterologists, Consultant Colorectal Surgeons, and Specialist 
Screening Practitioners. The original intention was to interview eight members of staff from 
each site. However, service pressures meant that some people we approached declined to be 
interviewed, or were subsequently unavailable. We therefore supplemented our interviews 
with a small number of staff from other sites, who had expressed an interest in being 
interviewed through the online survey. These interviewees were selected on the basis of 
maximum variation and filling ‘shortfalls’ in the job roles identified above from the original 
sites.  
 
Interviews were semi-structured, based on a topic guide that combined core questions with 
more detailed probes to clarify responses and explore issues in greater depth. On average 
they lasted 45 minutes and – with participants’ permission – were digitally recorded; they 
were then transcribed verbatim. Thematic analysis of the data was carried out, guided by the 
principles of Ritchie and Spencer’s Framework Approachcviii. This involves the initial 
identification of analytical themes derived from the research questions and existing literature, 
to which additional themes are added as new insights emerge from the data. The value of this 
approach is that it is particularly well suited to the problem-oriented nature of applied and 
policy relevant research, whilst also allowing for an analytical process which remains 
grounded in and driven by participants’ accounts.  
 
Appreciative enquiry event 
 
An Appreciative Inquiry (AI) study was carried out in one site, identified through the interviews 
as an example of good practice in managing its demand. 
 
The approach was semi-structured, focusing on the three domains of culture people, patients 
and placecix.  Problem areas are framed in a way that makes them more accessible to change 
and the facilitator explores with the teams creative ways in which improvements could be 
made.   
 
The aim of our analysis was to add to our understanding of the factors that support 
embedding research (from previous methods) in order to generate a more nuanced and 
realistic account of how and why things have worked well in a particular service. This enabled 
the research team to add significant value to the overall findings, by drawing on the positive 
experiences of people working in services where research is highly embedded, while also 
exploring aspirational ideas about what would be opportunities for the future. 
 
Online survey 
 
An online survey with mainly free text responses, on the challenges facing endoscopy units, 
was designed in order to achieve a broader reach of participants than was possible through 
interviews. The survey was constructed using Bristol Online Surveys and was distributed to all 
UK NHS and independent sector units through the JAG, at the same time as the JAG April 
2015 GRS census return was issued to sites. The number of responses (n=98) indicates a 21% 
response rate across all sectors.   
 
JAG census return 
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A number of additional questions were embedded into the JAG April GRS census return from 
endoscopy units to capture mainly quantitative data on activity and capacity, with some 
scope for providing additional free text comments.  
 
A total of 380 units responded across all sectors which equates to a 79% response rate. The 
number of returns received from NHS acute units only (n=207) indicates a 94% response rate 
for this sector, and it is these responses which are the focus of the subsequent analysis 
presented in this report. For a full set of findings, please visit the JAG website –
http://www.thejag.org.uk/downloads/National%20Policies%20and%20Reports/GRS%20censu
s%20unit%20information%20summary_April%202015.pdf 
 
Activity and demand model - Modelling Potential Changes in Gastro-Intestinal 
Endoscopy Activity in England between 2013/14 and 2019/20 
 
A model has been developed, which builds on baseline activity information to estimate future 
levels of demand for diagnostic endoscopies. The model provides activity estimates to 
2019/20. The model applies a series of multipliers to specific subsets of activity in the baseline 
year where each multiplier represents the impact of a specific change factor.  This method 
aims to maximise the independence of each of the change factors. 
 
The model can be described as predominantly static (i.e. the state of the model is largely time 
independent), explicit (i.e. the input parameters are considered to be fully known), continuous 
(i.e. endoscopies are not regarded as discrete events) and deterministic (i.e. no randomness in 
the system producing demand for endoscopies is considered). These design decisions were 
taken in light of the time available to build the model, the large number of model factors and 
to ensure transparency and thereby allow the widest review.   
 
The model uses the following datasets; 
• Hospital Episode Statistics (source : HSCIC) – a detailed, pseudonymised, record-level 
dataset of all inpatient episodes, outpatient attendances and accident and emergency 
department visits commissioned by the NHS in England 
• Diagnostic Imaging Dataset (source : HSCIC) – a pseudonymised record-level dataset 
of all diagnostic imaging activity commissioned by the NHS in England 
• BCSP Bowel Cancer Screening Programme data (source : BCSP) –a bespoke 
summary data extract showing counts of screening invitations, participation, 
diagnostic tests and screening outcomes by CCG (Clinical Commissioning Group), 
broad age groups and gender 
• Census of Endoscopy Units 2015 (source : JAG, Joint Accreditation Group) – all UK 
services are asked to complete the April GRS census, it is an on-line survey containing 
questions about organisation,  staffing, infrastructure, activity and training within 
endoscopy units 
• 2013 mid-year population estimates (source : ONS, Office of National Statistics) – 
estimates of the resident population of England by single year of age, gender and 
CCG (Clinical Commissioning Group)  
• 2012-based subnational population projections (source: ONS, Office of National 
Statistics) – estimates of future resident population by single year of age, gender and 
CCG 
• Monthly diagnostic waiting times and activity, DM01 (source : NHS England) – 
summary data showing the number of people waiting for a set of diagnostic tests by 
type of test, duration of wait to date, commissioner and provider and the number 
receiving tests by type, commissioner and provider.  
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• ONS Cancer Registrations, MB1 series (source: ONS, Office of National Statistics) –
Publications presenting data for England on those patients who were diagnosed with 
cancer during each year from 1995 to 2012 and whose registrations were received at 
the Office for National Statistics (ONS).  
• Two week waits referrals (source: National Cancer Intelligence Network) – summary 
data showing the number of 2-week-wait referrals by GP Practice. 
 
In addition, the model uses information derived from 
• Selected published studies and grey literature - individually referenced throughout this 
report 
• Interviews conducted by the project team as part of the wider project 
• Opinion of Expert Adviser, Dr Bob Walt, Gastroenterology - Consultant Physician, 
University Hospitals Birmingham NHS Foundation Trust 
• An informal reference group established by CRUK for this project 
• NHS England Endoscopy Stakeholder Meeting. 
 
 
Establishing Activity in the Baseline Year (2013/14) 
 
Three datasets were used to construct the baseline activity estimates; Hospital Episode 
Statistics, the Diagnostic Imaging Dataset and data supplied by the Bowel Cancer Screening 
Programme. 
 
Hospital Episode Statistics includes records of all patient contacts with NHS hospitals and 
NHS commissioned activity in private hospitals.  An extract of inpatient and outpatient hospital 
episode statistics was taken where the record included any relevant GI endoscopy procedure.   
Activity was grouped into categories; colonoscopy, flexible sigmoidoscopy, barium enema, 
upper GI endoscopy, upper GI endoscopic ultrasonography (EUS), endoscopic retrograde 
cholangiopancreatogram (ECRP) and hepato-pancreato-biliary endoscopic ultrasonography 
(HPB EUS).  The OPCS 4.7 procedure codes used to define the forms are endoscopy are set 
out in the table 5 below. 
 
Table 5 – Procedure codes used to define endoscopy procedures included within the 
model 
 
Form of GI endoscopic 
procedure 
OPCS 4 codes 
Colonoscopy H201, H202, H203, H204, H205, H206, H208, H209, 
H211, H212, H213, H214, H218, H219, H221, H228, H229, 
H681, H682, H683, H684, H688, H689 
Flexible sigmoidoscopy H231, H232, H233, H234, H235, H236, H238, H239, 
H241, H242, H243, H244, H248, H249, H251, H252, 
H258, H259, H691, H692, H693, H694, H698, H699 
Barium enema U174 
Upper GI endoscopy G141, G142, G143, G144, G145, G146, G147, G148, G149, 
G151, G152, G153, G154, G155, G156, G157, G158, G159, 
G161, G162, G163, G168, G169, G421, G422, G428, G429, 
G431, G432, G433, G434, G435, G436, G437, G438, 
G439, G441, G442, G443, G444, G445, G446, G447, 
G448, G449, G451, G453, G454, G458, G459, G461, 
G468, G469, G541, G542, G543, G548, G549, G551, 
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G558, G559, G641, G642, G643, G648, G649, G651, 
G658, G659, G791, G792, G793, G798, G799, G801, 
G802, G803, G808, G809 
Upper GI EUS G452 
Endoscopic retrograde 
cholangiopancreatography 
(ECRP) 
J381, J382, J388, J389, J391, J398, J399, J401, J402, 
J403, J404, J405, J406, J407, J408, J409, J411, J412, 
J413, J414, J418, J419, J421, J422, J423, J424, J425, 
J428, J429, J431, J432, J433, J438, J439, J441, J448, 
J449, J451, J452, J453, J458, J459 
Hepato-pancreato-biliary EUS J531, J538, J539, J741, J748, J749 
 
Although CT colonoscopy procedures are in some cases recorded in HES, the Diagnostic 
Imaging Dataset (DID) is thought to be a more complete dataset for imaging activity.  DID 
includes all diagnostic imaging activity carried out in NHS hospitals and NHS commissioned 
activity carried out in private hospitals.  CT colonoscopy activity was defined as the activity 
with either the SnomedCT code 418714002 or the National Interim Clinical Imaging 
Procedure (NICIP) code CVCOY. 
 
Data extracts were supplied by Bowel Cancer Screening programme for the purposes of this 
project.  These extracts include; 
• The number of subjects invited, responding, receiving an endoscopic procedure and 
receiving a diagnosis through the bowel scope screening programme by CCG, 
gender and financial year  
• The number of subjects invited, receiving and returning kits, positively screened, 
receiving endoscopic or imaging procedure  and receiving a diagnosis though the 
faecal occult blood test (FOBT) programme  by CCG, age group, gender and financial 
year. 
 
CT colonoscopy activity records from DID were assigned to a single inpatient or outpatient 
record in HES using a probabilistic data linkage method.  CT colonoscopy records from DID 
were linked on a patient basis to all inpatient and outpatient HES records for the same 
individual29.  Each linked HES record was then ranked based on the correspondence of a 
range of fields in HES and DID including the procedure dates and the procedure setting.  Each 
DID record was matched to the single HES record with the highest rank.  These CT 
colonoscopy records were then appended to the HES records for other forms of endoscopy.   
 
The model requires activity to be assigned to one of three cohorts; screening (FOBT / Bowel 
Scope), symptomatic (emergency / non-emergency) and surveillance (including follow up), 
since many of the change factors apply specifically to one or more of these activity subsets. 
Given that HES and DID activity is not explicitly defined in these terms, an algorithm was 
developed to assign activity to these three cohorts.  The first steps in this algorithm are set out 
in the table below.  These rules are applied in a specific order.  Only activity not assigned to a 
cohort by an earlier rule is available to be assigned by a later rule. 
 
 
Table 6 – Rules governing assignation to activity cohort 
 
                                                        
29
 The HES and DID were pseudonymised by the Health and Social Care Information Centre using the 
same algorithm and pseudonymisation key such that an individual within the two datasets could be 
uniquely identified without the need for personal identifiable data. 
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Rule 
order 
Rule Assigned Cohort 
1 Elective inpatient or routine outpatient activity for patients 
with diagnosis in HES of GI cancer, inflammatory bowel 
disease or Barrett’s oesophagus between 2004/5 and 
2012/13 
Surveillance 
2 Elective inpatient or routine outpatient activity for patients 
with diagnosis in HES indicating endoscopy activity follow-
up of treatment for GI cancer, inflammatory bowel disease 
or Barrett’s oesophagus in 2013/14 
Surveillance 
3 Planned inpatient activity with earlier HES activity 
indicating a history of endoscopy for the relevant 
anatomical site between 2004/5 and 2012/13. 
Surveillance 
4 Emergency inpatient activity Symptomatic 
 
5 Colonoscopy and flexible sigmoidoscopy activity for 
patients aged 55 or 60 to 74  
Screening or 
Symptomatic 
(see 4.7 below) 
6 All other activity Symptomatic 
 
 
Activity assigned to the ‘screening or symptomatic’ cohort are apportioned to the screening 
or symptomatic cohorts by analysing activity rates in the ages eligible for the screening 
programmes30  with the activity rates in the ages immediately above and below these eligible 
age groups31.  Activity in the eligible age groups at the average rates in the age groups 
immediately above and below, were assigned to the symptomatic cohort.  This analysis was 
conducted by CCG and gender. Residual activity was assigned to a potential screening 
cohort. 
 
Given concerns about the completeness of recording of endoscopy activity carried out as 
part of the Bowel Cancer screening programme (BCSP) in HES32, the activity assigned to the 
potential screening cohort in the augmented HES extract was adjusted to match the activity 
levels in the data obtained from BCSP.  Adjustments were made by BCSP programme, 
endoscopy procedure, CCG, age, gender and outcome.33  Over-estimates of screening 
activity in the potential screening cohort were re-designated back to symptomatic cohort – 
see Fig10 below. 
 
                                                        
30
 60-74 years for FOBT and 55 years for Bowel Scope 
31
 57-59 & 75-77 years for FOBT and 52-54 & 56-58 years for Bowel Scope 
32
 source: Letter from Prof. Erika Denton, National Clinical Director for Diagnostics and Dr Michael 
Glynn, National Clinical Director GI & Liver Disease, NHS England to NHS Trusts re : Reporting BCSP 
endoscopy activity in HES, 30
th
 October 2014. 
33
 Artificial records were created for CCGs that had no record of bowel scope activity in the baseline 
year to allow an assessment of the model change factors.  These artificial records were subtracted at 
the end of the modelling process. 
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Figure 10: establishing activity in the baseline year 
 
The final baseline dataset was then grouped and summarised by procedure type, cohort, 
condition/diagnosis, age, gender, CCG and relevant previous diagnoses. 
 
Factors Expected to Influence Demand and Supply of Endoscopy 
 
A set of change factors for the model were agreed through discussions with the project’s 
expert advisor, the Cancer Research UK reference group and the NHS England Endoscopy 
Stakeholder Group.  These represent the key factors that were thought to have the greatest 
influence on demand for endoscopy over the time horizon of the model.  
 
Adjustment of baseline activity to match demand in the baseline year 
 
• Diagnostic waiting time (DM01) returns indicate some variance between demand and 
supply in the baseline year.  Before other change factors are incorporated into the 
model, adjustments are made to activity levels in the baseline year to bring demand 
and supply back into equilibrium.   
 
• For each CCG and procedure type, we calculate the change in waiting list size 
between the ends of 2012/13 and 2013/14. Where waiting lists have grown, we 
conclude that supply was not adequate to meet demand and activity in the baseline 
year is adjusted upwards accordingly.  Similarly where waiting lists reduced we 
attribute this to non-recurrent initiatives and adjust activity in the baseline year 
downwards. 
 
• These adjustments are applied as multipliers to screening FOBT and non-emergency 
symptomatic activity.  Differential multipliers are applied by CCG and procedure type.  
 
Demographics and Population Health Status 
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Population Size and Age Profile 
 
• ONS sub-national population projects indicate changes in population size, gender and 
age profile by CCG.   
 
• Subnational population projections are published by calendar rather than financial 
year.  Population projections for a financial year, y/y+1 are estimated as (3py+py+1)/4 
where pn is the population projection in year n. 
 
• Multipliers are calculated as the quotient of the population in 2019/20 and the 
population in 2013/14. Differential multipliers are applied by CCG, age and gender to 
all activity in the baseline year to increase / decrease activity in line with these 
population projections. 
 
Cancer Incidence 
 
• Whilst changes in population size and age profile might be seen as the primary driver 
of changes in cancer incidence, there are also subtle trends in cancer incidence within 
age strata.  National ONS cancers registration trends were plotted by invasive cancer 
sites, gender and denary age strata (18-39 est., 40-49, 50-59, 60-69, 70-79, 80+) 
between 2003 and 2012.  The trends appeared broadly linear and so linear 
extrapolation was used to forecast rates to 2019/20.34    
 
• Multipliers were calculated by invasive cancer type (ICD10 groupings: upper GI C15-17, 
colorectal C18-20, HPB C22-25, other digestive C26), gender and age group as the 
quotient of the rate in 2019/20 and 2013/14.   
 
• Given concerns about the completeness of registrations of non-malignant tumours 
including benign colorectal neoplasms (e.g. adenomas), we assume that age specific 
changes in non-malignant tumours follow the same trajectory as those of invasive 
tumours. 
 
• These multipliers are applied to symptomatic activity for cancer.  Differential 
multipliers are applied by age, gender and cancer site. 
 
Cancer Survivorship 
 
• If cancer survivorship increases then we might reasonably expect increases in 
surveillance activity following cancer.  A paper in the British Journal of Cancercx 
includes estimates of future increases in invasive cancer survivorship by cancer site 
and gender.  These increases assume changes in population size and age profile and 
given that this effect is accounted for elsewhere in the model, the published annual 
increases in cancer survivors were adjusted accordingly to remove these 
demographic effects.  Multipliers were then taken as the (1+s)6 where s is the adjusted 
annual increase in cancer survivors. 
 
• These multipliers are applied to surveillance activity following cancer.  Differential 
multipliers are applied by gender and cancer site. 
                                                        
34
 Incidence in 60-69-year-olds will have been inflated due to the roll out of bowel screening in the 
late 2000s which may mean that this linear trend overestimates increase in incidence trend. 
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Barrett's Oesophagus Incidence 
 
• Age specific incidence of Barrett’s oesophagus is thought to be increasingcxi and we might 
expect this to lead to an increase in upper GI endoscopy activity.  Following 
correspondence with Dr Helen Coleman and Prof. Liam Murray, trends between 2006 
and 201035 were used to forecast the number of new cases of Barrett’s oesophagus to 
2019/20. 
 
• Multipliers derived from these forecasts were applied to symptomatic activity for Barrett’s 
oesophagus.  Differential multipliers were applied by gender and broad age group (<60, 
60-79, 80+). 
 
Strategies and Initiatives 
 
Screening > Surveillance 
 
• Screening activity will lead to an increase in the identification of patients with disease.  
This in turn may lead to increased demand for surveillance endoscopies.  A simple 
Markov model was developed to estimate the increase in surveillance activity that 
might result from screening. 
 
• Data from the BCSP included information on the number and type of diagnoses 
resulting from the FOBT and Bowel Scope screening programmes.  Recommended 
surveillance intervals were taken from NICE Guideline CG118.  1 and 5 year age-
standardised colorectal cancer survival rates were taken from Cancer Research UK36 
and geometric interpolation was used to estimate survival at years 2, 3 and 4.  Survival 
rates for non-cancer cases were assumed to be equivalent to the background age-
specific mortality rates.   
 
• The increase in surveillance activity by 2019/20 was used to derive activity multipliers 
for lower GI surveillance activity for cancer and adenomas.  Differential multipliers 
were applied by procedure type, surveillance condition and risk level. 
 
 
BCSP: FOBT > FIT 
 
• There is growing evidence of the benefits of using the Faecal Immunochemical Test 
(FIT) over the presently used guaiac Faecal Occult Blood Test (FOBT).  FIT delivers 
higher uptake, higher positivity rates and improved positive predictive valuescxii.  
Furthermore, early data from the BCSP FIT pilots also indicate that FIT also archives 
greater uptake in the most deprived subsets of the population and therefore improves 
equity. 
 
• We used van Rosum’s papercxiii to estimate the likely change on screening initiated and 
surveillance endoscopy activity should the screening programme move from FOBT to 
FIT in 2017/18.  
                                                        
35
 since these were thought to best reflect changes in incidence rather than ascertainment 
36
 http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/survival/bowel-cancer-
survival-statistics  
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• The ratio of endoscopies generated via FIT and FOBT as a direct consequence of a 
screening programme from van Rosum were applied to the current rate of 
endoscopies per invited patient (from data supplied by BCSP).  The impact on 
surveillance activity was estimated by adjusting the Markov model described above by 
multiplying the number of cancers and adenomas currently detected by the 
programme by the ratio of detections via FIT and FOBT in van Rosum.  
 
BCSP: Raise FIT Positivity Threshold 
 
• The impact of any planned move from FOBT to FIT is likely to be considerable; van 
Rosum found that the number of screening initiated endoscopies increased almost 
threefold as a result of higher uptake and positivity of FIT. Given the additional demand 
that this may generate for endoscopy services, the screening programme have 
indicated that they may introduce a temporary measure to minimise this impact. The 
threshold used to indicate a positive result from FIT is conventionally set at 20 µg Hb / 
g faeces37.  Alternative positivity threshold can be selected to increase or decrease 
positivity thresholds.  BCSP FIT pilots38 indicate that a threshold of 180 µg Hb / g 
faeces would generate a similar level of endoscopies as the current FOBT based 
programme.  At this higher positivity threshold the positive predictive value remains 
substantially higher than for FOBT. We have therefore assumed that the FIT test will be 
used at this higher positivity threshold until at least 2019/20, the time horizon of this 
project.  It should be noted however, that BCSP intend to revert to the conventional 
positivity threshold as soon as endoscopy services can accommodate the additional 
demand.   
 
 
 
 
 
BCSP: Bowel Scoping Roll-Out 
 
• Since 2013, the Bowel Cancer Screening Programme has been piloting a new 
screening test in which a flexible sigmoidoscopic examination is offered to men and 
women at age 55.  
 
• Data from the BCSP provided information on the numbers of patients invited and the 
number of flexible sigmoidoscopies and colonoscopies carried out in the pilot areas in 
2013/14 and 2014/15.  These figures were used to estimate the number of additional 
flexible sigmoidoscopies and colonoscopies that would be carried out if this pilot was 
rolled out nationally by 2019/20.  Differential multipliers were applied by CCG and 
gender. 
 
• The Markov model described above was adjusted to reflect the increase in 
surveillance activity that would be generated as the Bowel Scope screening 
programme was progressively rolled out, achieving full roll-out by 2019/20. 
 
Increase and reduce variation in two-week-wait referrals 
                                                        
37
 equivalent to 100 ng Hb / mL of buffer solution for the OC Sensa test.   
38
 Personal correspondence Professor Stephen Halloran 
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• Qualitative interviews conducted as part of the wider project indicated issues with 
both the level and consistency of two-week-wait (2WW) referrals for suspected 
cancer.  
 
• GP practice two-week-wait referral rates (number of referrals per head of practice 
population) for suspected lower GI cancers in 2014 were obtained from the NCIN 
commissioning toolkit.  Two adjustments were made to the distribution of two-week-
wait by GP practice – see Fig 11 below.  The level of variation between GP practices is 
reduced by half (such that only 0.24% of GP practices fall more than 1.96 standard 
deviations from the mean) and the rates were increased (such that the new mean rate 
is equal to the current upper quartile rate, from 372 to 419 referrals per 100,000 
registered patients). 
 
 
Figure 11: estimating the future distribution of GP two-week wait referrals 
 
 
• The baseline number of 2WW lower GI endoscopy procedures was calculated from 
CCG level referral counts assuming, based on the qualitative interviews, that the 
conversion rate of referral to procedure was 85%. Similarly the expected lower GI 
endoscopy procedures were calculated from the adjusted distribution of referrals. The 
difference in the number of procedures due to changes in 2WWs was used to 
calculate multipliers for non-emergency symptomatic lower GI endoscopy 
procedures.   
 
• Due to the lack of available data on 2WWs of upper GI and HPB suspected cancers we 
assume that upper GI and HPB multipliers are the same as lower GI.  
 
• Multipliers were applied for non-emergency symptomatic activity.  Differential 
multipliers were applied by CCG. 
 
 
Barrett's Surveillance 
 
• Approaches to surveillance following diagnosis for Barrett’s oesophagus are thought 
to be inconsistent.  The underlying prevalence of Barrett’s oesophagus is thought to 
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be approximately 2% of the adult populationcxiv.  We calculated surveillance activity 
rate for Barrett’s oesophagus by CCG. 
 
• To reflect increasing consistency in Barrett’s oesophagus surveillance we assumed 
that any CCG with a surveillance activity rate below the CCG upper quartile in 2013/14 
will increase to this level by 2019/20.  Multipliers were applied to surveillance activity 
for Barrett’s oesophagus.  Differential multipliers were applied by CCG. 
 
New NICE Cancer Referral Guidelines 
 
• Cancer referral guidelines were recently updated by NICE and were published in June 
2015.  The guidelines change the criteria and thresholds that should be applied when 
determining whether to refer a patient for suspected cancer.  Estimates of the impact 
of these guidelines on endoscopy activity were contained in a NICE costing report 
(http://www.nice.org.uk/guidance/NG12/documents/suspected-cancer-update-
costing-report2) that was published alongside the draft guidelines. (Note that these 
figures were not updated when the final guidelines were published).  This model 
suggested that the change in referral criteria and thresholds would result in an 
increase of between 5% and 15% of referrals for lower GI endoscopies.  We initially 
used the mid-point of this interval to derive multipliers for lower GI symptomatic 
activity.  However, following feedback from the NHS England Endoscopy Stakeholder 
Group39, we instead used the upper limit of the interval.  Furthermore, we assumed 
that 85% of lower GI referrals would result in an endoscopy. 
 
• The costing report concluded that guidelines would not result in changes in upper GI 
endoscopy activity although there would be greater use of direct access tests. 
 
Public Awareness Campaigns 
 
• Provisional analysis by Cancer Research UK40 for NHS England estimates the increase 
in waiting list endoscopy activity as a result of public awareness campaigns which 
encourage patients to contact their GP if they experience certain symptoms.  CR-UK 
analyses relate to one local pilot upper GI (Oesophago-Gastric cancer) campaign and 
one lower GI (bowel) cancer campaign (with a follow up reminder campaign – not 
used here) and compared change in endoscopy activity before, during and after the 
campaigns in the pilot and control areas.  The difference in observed change in 
endoscopy activity (pilot vs control) is attributed to the campaigns.  We have assumed 
that the effect of a campaign in any given year is for six months, three months at the 
‘during campaign’ level and three months at the ‘after campaign’ level. 
 
• Since no forward plan for public awareness campaigns existed at the point of model 
development, we have assumed that there will be one additional lower GI campaign 
and one additional upper GI campaign in 2019/20 in comparison to 2013/14. 
 
                                                        
39
 One of the stated objectives of the NICE Guideline NG12 is to reduce the positive predictive value of 
GP referrals for suspected cancer from 5% to 3%.  At face value one might expect this to lead to a 67% [ 
0.05 / 0.03 -1] increase in referral activity before any additional cancers are detected. 
40
 Evaluation of the Be Clear on Cancer Oesophago-Gastric Cancer Awareness Local Pilot: April to July 
2012, CRUK; evaluation of campaigns post-2013 is led by NCIN 
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• Multipliers were calculated for screening and non-emergency symptomatic activity 
and applied by procedure type. 
 
Technological Change 
 
Decommissioning Barium Enema 
 
• Levels of barium enema activity have decreased rapidly in recent years following NICE 
guidelines about the efficacy of this procedure for diagnostic purposes.  We have 
assumed that all remaining barium enema activity will be eliminated by 2019/20 and 
replaced by either CT colonoscopy or colonoscopy.  
 
• We reviewed the primary and secondary diagnoses of patients receiving a barium 
enema in the baseline year and concluded that approximately 93% would be suitable 
for CT colonoscopy whereas the remaining 3% for whom there was evidence of a GI 
bleed / haemorrhage (ICD10 code K922 or K625), may require a colonoscopy. 
 
Zero multipliers were included in the model for barium enema activity.  Multipliers were 
calculated for colonoscopy and CT colonoscopy activity to reflect the anticipated increase in 
these procedures as a substitute for barium enemas. 
 
Increasing Use of CT Colonoscopy 
 
• Rates of CT colonoscopy have increased substantially in recent years.  Changes in 
need (demography, disease incidence / prevalence) and substitution for barium 
enema activity can explain only part of this growth and we assume that the remainder 
is attributable to the diffusion of this new technology.  University College London 
Hospital Trust is seen as an early adopter of this new technology.  For the purposes of 
this model we have assumed that rates of CT colonoscopy will increase such that all 
CCGs deliver at least the rate per head of patients aged 75+ delivered by UCL to the 
CCGs of Camden and Islington in 2013/14.  The Camden and Islington CCG rates 
were adjusted to reflect the fact that other provider trusts deliver endoscopy services 
to these patients.  CCGs with CT colonoscopy rates (per head of population aged 75) 
higher than the Camden and Islington CCG rates were not changed. 
 
• Analysis of the Diagnostic Imaging Dataset (DID) and Hospital Episode Statistics (HES) 
in 2013/14 indicates that approximately 10.2% of patients receiving a CT colonoscopy 
receive a colonoscopy shortly afterwards.  We therefore increase colonoscopy activity 
as CT colonoscopy activity increases using 10.2% as the conversion ratio. 
 
• Multipliers are created for all CT colonoscopy activity and for non-emergency 
symptomatic colonoscopy activity.  Differential multipliers are applied by CCG. 
 
Interaction between Model Factors 
 
The multiplicative nature of the model recognises that the model factors interact rather than 
act in isolation. The combined effect of the change factors is greater than the sum of the 
individual effects.  The model results report the individual effects of each of the change 
factors as well as the impact of any interaction between the model factors.  The difference 
between the sum of the individual effects of the change factors and their combined impact is 
equivalent to all of the 2-way, 3-way, 4-way etc. interactions between the change factors.  
 
CONFIDENTIAL: EMBARGOED UNTIL 00:01 03/09/15 
 
 
82 
 
As an example, the model estimates the impact of bowel scope alone is to increase the 
annual number of endoscopies by c. 265k, but this assumed that nothing else changes (e.g. 
population at 13/14 level).  However the population aged 55 will grow between the baseline 
and final year and so the population age profile and the bowel scope factors will interact to 
create a larger effect.   
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Appendix 2. Local interviews topic guide   
 
Question 1.  
 
Main question: Can you start by telling me a bit about your own particular involvement in the 
delivery of endoscopy services? 
 
Possible probes: 
• If involved clinically in undertaking endoscopic tests – which ones and how often do they 
undertake lists?  
• Some contextual information on the size of their unit 
• If a commissioner – what are arrangements for considering endoscopy services – part of 
a diagnostics sub-group of CCG? Or endoscopic specific across a number of CCGs?  
• If commissioner – how many providers within their patch and configuration of providers 
i.e. community provision, private providers etc.?  
 
 
Question 2. 
 
Main question: A great deal of service improvement type work has been done over the 
course of the last few years with endoscopy services, through the work of the JAG and 
accreditation and the NHS Improvement Agency (now NHS IQ). How familiar are you with 
this work? Is it relevant to your everyday practice? Do you think things have changed in your 
unit as a result of these national initiatives? 
 
Possible probes: 
• What has improved? 
• And what can still be improved further? Are there any specific causes of wastage, or 
inefficient practice within your unit that you are working to address?  
• If a commissioner - were they expecting this work to deliver specific benefits that have 
not yet been realised? And if so, why do they think this is? 
 
 
Question 3. 
 
Main question: What do you see as the key challenges facing your endoscopy service now 
and over the course of the next five years in managing demand? 
Possible probes:  
• Challenges in relation to accommodating bowel screening programmes? 
• Challenges in relation to impact of other cancer awareness campaigns? 
• NICE guidance proposed changes  - referral threshold changes – (people don’t have 
to have had symptoms for six weeks – no time duration required) 
• To what extent is the ability of your unit to manage GI endoscopy demand affected by 
other activity that you might undertake? What sorts of activities are these (e.g. 
bronchoscopy, cystoscopy, clinical research etc.)? 
• For commissioners – do they know what the key challenges are facing the endoscopy 
services they commission?  
 
 
Question 4. 
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Main question: What is your unit doing to increase its capacity to cope with rising demand? 
Possible probes:  
• Physical space – planned capital developments? 
• 7 day working/3 session days? 
• Waiting List Initiatives? 
• Developing a more flexible workforce? Nurse Endoscopists, GP Practitioners? 
• How is your unit thinking about job design to ensure roles are attractive and 
sustainable? 
• What role do private providers have in helping your unit manage demand? 
• Changes to surveillance protocols?  
• Is anyone within your organisation providing your unit with support to address these 
challenges?   
• Is anyone from outside your organisation providing support i.e. SCNs? 
• For commissioners – what are the providers of your endoscopy services doing to 
cope with rising demand? 
 
 
Question 5.  
 
Main question: How effective have local commissioners been in supporting your unit with 
these challenges? 
 
Possible probes:  
• What role have they played to date that they are aware of? (Developing 
commissioning strategies, commissioning only JAG accredited units, increasing 
investment, direct access arrangements?  
• How do tariff payments affect what they do within the unit? Does it have any impact 
on their strategic plans? 
• For commissioners – what are you doing to support your providers of endoscopy 
services with these challenges? 
 
 
Question 6.  
 
Main question: Do you think more endoscopy work could be undertaken within the 
community? 
 
Possible probes:  
• Screening only centres? Or surveillance of low risk patients in the community? 
• What are the opportunities? 
• What are the constraints? 
 
 
Question 7.  
 
Main question: What innovations in the provision of endoscopy services are likely to have an 
impact on demand over the course of the next five years? 
 
Possible probes:  
• Likely increase in virtual colonoscopy (CT colonography)? 
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• Trans-nasal endoscopy? 
• Faecal calprotectin (investigation of diarrhoea) 
• Straight to test? (How is triage for this being performed – by Nurse 
Endoscopists/specialist endoscopy nurses/paper questionnaire etc?)  
 
Question 8.  
 
Main question: How are patients/members of the public involved at a local level to influence 
the patterns of provision of services, or service development? 
 
Possible probes: 
• Is patient feedback routinely collected in the unit? 
• What sorts of comments do people make about the experience of having an 
endoscopy? 
• Has the unit changed anything as a result of patient/public feedback? 
• For commissioners – are they aware of any feedback/comments from their patients 
about the provision of endoscopy services? i.e. they want weekend sessions for bowel 
screening etc? 
 
 
Question 9.  
 
Main question: Are there any particular aspects of good practice in managing capacity and 
demand that your unit would like to share with others? 
 
 
Question 10. 
 
Main question: Is there anything else you would like to add that you think may be helpful or 
informative to this study?  
 
 
Thanks and close. 
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